syndrome	score	normalized_score
PHACE ASSOCIATION	1.000545554	100.0
ATELOSTEOGENESIS TYPE II	1.0	99.94547434668829
CLEFT PALATE, DEAFNESS, AND OLIGODONTIA	1.0	99.94547434668829
NORRIE DISEASE	1.0	99.94547434668829
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	99.94547434668829
CLEFT LIP/PALATE	0.75	74.95910576001621
CHAR SYNDROME	0.500545554	50.02726282665587
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.500545554	50.02726282665587
TETRASOMY 9P	0.500545554	50.02726282665587
CLEFT PALATE-STAPES FIXATION-OLIGODONTIA SYNDROME	0.5	49.97273717334414
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.3480389	34.78491295159961
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.33950584	33.932072222270854
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.333878554	33.369650453716375
PALLISTER-HALL SYNDROME	0.333878554	33.369650453716375
PALLISTER-HALL SYNDROME	0.333878554	33.369650453716375
TUFTED ANGIOMA	0.3333333	33.315154784046946
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.333333	33.31512480040465
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.333333	33.31512480040465
C SYNDROME	0.333333	33.31512480040465
NON-INVOLUTING CONGENITAL HEMANGIOMA	0.333333	33.31512480040465
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	33.31512480040465
RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA	0.333333	33.31512480040465
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	33.31512480040465
ACITRETIN/ETRETINATE EMBRYOPATHY	0.333333	33.31512480040465
PLACENTAL INSUFFICIENCY	0.333333	33.31512480040465
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	33.31512480040465
CONGENITAL ENTEROVIRUS INFECTION	0.3269231	32.67448430438981
NON-DISTAL MONOSOMY 20Q	0.28966551	28.950756798825378
SECKEL SYNDROME 2; SCKL2	0.2822581	28.210419692694977
ROBERTS SYNDROME; RBS	0.2647059	26.456156737867033
8P INVERTED DUPLICATION/DELETION SYNDROME	0.25740741	25.726705692802472
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.250545554	25.040894239983803
HYPERTRICHOSIS CUBITI	0.250545554	25.040894239983803
ROBERTS SYNDROME	0.250545554	25.040894239983803
TETANUS	0.25	24.98636858667207
TERMINAL OSSEOUS DYSPLASIA; TOD	0.25	24.98636858667207
HYPERPARATHYROIDISM 2	0.25	24.98636858667207
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.25	24.98636858667207
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	24.98636858667207
TEMPLE SYNDROME	0.25	24.98636858667207
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.25	24.98636858667207
AMERICAN TRYPANOSOMIASIS	0.25	24.98636858667207
WEST SYNDROME	0.25	24.98636858667207
NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL	0.25	24.98636858667207
DYSTONIA 6, TORSION	0.25	24.98636858667207
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.196843854	19.673652360260256
SMITH-LEMLI-OPITZ SYNDROME	0.185394354	18.529326651727846
PITYRIASIS RUBRA PILARIS	0.18333370000000002	18.323373610233446
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.167212554	16.712138026251232
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.166667	16.657612372939496
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.166667	16.657612372939496
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	16.657612372939496
PEMPHIGUS VULGARIS	0.166667	16.657612372939496
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.166667	16.657612372939496
PFAPA SYNDROME	0.166667	16.657612372939496
GRANULOMATOSIS WITH POLYANGIITIS	0.166667	16.657612372939496
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	16.657612372939496
BECKWITH-WIEDEMANN SYNDROME	0.16025640000000002	16.016901915092618
SCHINZEL-GIEDION SYNDROME	0.12599204000000003	12.592334201706926
RING CHROMOSOME 7 SYNDROME	0.10544661000000001	10.538911454700244
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.08635400000000001	8.63069149173392
3C SYNDROME	0.08387885400000002	8.383311850686614
BOHRING-OPITZ SYNDROME	0.08387885400000002	8.383311850686614
CHROMOSOME 16P13.3 DELETION SYNDROME	0.08387885400000002	8.383311850686614
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08386754	8.382181067589853
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.08333330000000001	8.32878619737488
STURGE-WEBER SYNDROME	0.08333330000000001	8.32878619737488
NATIVE AMERICAN MYOPATHY	0.08333330000000001	8.32878619737488
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.08333330000000001	8.32878619737488
LARYNGOTRACHEAL ANGIOMA	0.08333330000000001	8.32878619737488
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.08253970000000001	8.249469468933347
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.08133220999999999	8.128786308114462
ADNP SYNDROME	0.08133220999999999	8.128786308114462
ROTHMUND-THOMSON SYNDROME	0.078303394	7.826069856285625
TRISOMY 8P	0.07692310000000001	7.6881157177177375
ETHYLMALONIC ENCEPHALOPATHY	0.07692310000000001	7.6881157177177375
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	7.6881157177177375
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	7.6881157177177375
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	7.6881157177177375
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.07692310000000001	7.6881157177177375
TUBEROUS SCLEROSIS COMPLEX	0.07692310000000001	7.6881157177177375
DDOST-CDG	0.07692310000000001	7.6881157177177375
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.07692310000000001	7.6881157177177375
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07692310000000001	7.6881157177177375
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07392479999999998	7.388449201984059
COFFIN-SIRIS SYNDROME 3; CSS3	0.07197415400000001	7.193490962231593
DOORS SYNDROME	0.07197415400000001	7.193490962231593
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.07197415400000001	7.193490962231593
CONGENITAL NEPHROTIC SYNDROME, FINNISH TYPE	0.07142860000000001	7.138965308919859
PYCNODYSOSTOSIS	0.07142860000000001	7.138965308919859
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.07142860000000001	7.138965308919859
CLEIDOCRANIAL DYSPLASIA; CCD	0.07142860000000001	7.138965308919859
BRACHYDACTYLY, TYPE B1	0.07142860000000001	7.138965308919859
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.07142860000000001	7.138965308919859
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.07142860000000001	7.138965308919859
JOHANSON-BLIZZARD SYNDROME; JBS	0.0673375	6.730078378820122
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0611888	6.115543640704639
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.06020060000000001	6.016777522955243
HYPODONTIA-DYSPLASIA OF NAILS SYNDROME	0.05957604	5.9543555774972745
DUBOWITZ SYNDROME	0.05957604	5.9543555774972745
PHEOCHROMOCYTOMA	0.0531117	5.308274049859003
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0526316	5.260290227625159
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0526316	5.260290227625159
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0526316	5.260290227625159
WITKOP SYNDROME	0.0526316	5.260290227625159
OROFACIODIGITAL SYNDROME I; OFD1	0.0526316	5.260290227625159
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.0526316	5.260290227625159
257960 OCULOTRICHODYSPLASIA; OTD	0.0526316	5.260290227625159
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.0526316	5.260290227625159
ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE	0.0526316	5.260290227625159
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.0526316	5.260290227625159
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0526316	5.260290227625159
CHAND SYNDROME	0.0526316	5.260290227625159
PERIODONTAL EHLERS-DANLOS SYNDROME	0.0526316	5.260290227625159
TOOTH AGENESIS, SELECTIVE, 7	0.0526316	5.260290227625159
OCULODENTODIGITAL DYSPLASIA	0.050439899999999996	5.041239731499521
SECKEL SYNDROME	0.050439899999999996	5.041239731499521
AICARDI SYNDROME	0.04907410999999999	4.904735202091557
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.04907410999999999	4.904735202091557
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.04907410999999999	4.904735202091557
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.04907410999999999	4.904735202091557
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.04785354	4.782744754468221
9P13 MICRODELETION SYNDROME	0.046964	4.693839257217868
WATSON SYNDROME	0.0454546	4.542981558238977
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0432779	4.32543024422854
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.043163394	4.313985887742999
LISSENCEPHALY, X-LINKED, 2	0.04312171000000001	4.309819760590332
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.04312171000000001	4.309819760590332
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	4.309819760590332
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.04312171000000001	4.309819760590332
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.04188714	4.186430076326141
49,XXXYY SYNDROME	0.041666699999999994	4.164398095961156
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.041666699999999994	4.164398095961156
49,XYYYY SYNDROME	0.041666699999999994	4.164398095961156
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.041666699999999994	4.164398095961156
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	4.164398095961156
HAMAMY SYNDROME; HMMS	0.041666699999999994	4.164398095961156
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	4.164398095961156
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.041666699999999994	4.164398095961156
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.041666699999999994	4.164398095961156
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	4.164398095961156
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	4.164398095961156
XQ12-Q13.3 DUPLICATION SYNDROME	0.041666699999999994	4.164398095961156
PGM3-CDG	0.041666699999999994	4.164398095961156
XP22.13P22.2 DUPLICATION SYNDROME	0.041666699999999994	4.164398095961156
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.041666699999999994	4.164398095961156
HISTIDINEMIA	0.041666699999999994	4.164398095961156
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.041666699999999994	4.164398095961156
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.041454653999999994	4.143205057907838
PROTEUS SYNDROME	0.0409091	4.088679404596105
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0409091	4.088679404596105
MOEBIUS SYNDROME	0.0409091	4.088679404596105
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	3.9946906805204794
FETAL HYDANTOIN SYNDROME	0.039939553999999995	3.991777669725171
BRANCHIO-OCULO-FACIAL SYNDROME	0.039920899999999995	3.9899132868467073
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.03966551	3.9643882121533074
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.039394	3.937252016413438
ATAXIA-TELANGIECTASIA	0.039394	3.937252016413438
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.039202539999999994	3.9181164558950203
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.039007054	3.898578514896885
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	3.8440528615851517
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	3.8440528615851517
JUVENILE MYOCLONIC EPILEPSY	0.0384615	3.8440528615851517
LIP, HAMARTOMATOUS	0.0384615	3.8440528615851517
ACROCEPHALOPOLYDACTYLY	0.0384615	3.8440528615851517
SHPRINTZEN OMPHALOCELE SYNDROME	0.0384615	3.8440528615851517
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	3.8440528615851517
LIP, MEDIAN NODULE OF UPPER	0.0384615	3.8440528615851517
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	3.8440528615851517
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	3.8440528615851517
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	3.8440528615851517
BAZEX SYNDROME; BZX	0.0384615	3.8440528615851517
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	3.8440528615851517
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	3.8440528615851517
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	3.8440528615851517
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	3.8440528615851517
CYCLIC NEUTROPENIA	0.0384615	3.8440528615851517
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	3.8440528615851517
JUVENILE ABSENCE EPILEPSY	0.0384615	3.8440528615851517
MAL DE MELEDA	0.0384615	3.8440528615851517
SILVER-RUSSELL SYNDROME; SRS	0.037978753999999997	3.7958045836261847
SILVER-RUSSELL SYNDROME	0.0374332	3.741278930314452
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.036990554	3.6970384658767874
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.0366645	3.664450844184153
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.036445	3.642512812565054
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036259854	3.6240083077716623
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.036259854	3.6240083077716623
YOU-HOOVER-FONG SYNDROME; YHFS	0.036259854	3.6240083077716623
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.036259854	3.6240083077716623
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.036259854	3.6240083077716623
ZELLWEGER SYNDROME	0.035714300000000004	3.5694826544599296
AMISH INFANTILE EPILEPSY SYNDROME	0.035714300000000004	3.5694826544599296
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.035714300000000004	3.5694826544599296
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.035714300000000004	3.5694826544599296
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.035714300000000004	3.5694826544599296
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.035714300000000004	3.5694826544599296
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.035714300000000004	3.5694826544599296
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.035714300000000004	3.5694826544599296
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.035714300000000004	3.5694826544599296
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.035714300000000004	3.5694826544599296
MICROHYDRANENCEPHALY; MHAC	0.035714300000000004	3.5694826544599296
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.035714300000000004	3.5694826544599296
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.035714300000000004	3.5694826544599296
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.035714300000000004	3.5694826544599296
SLC39A8-CDG	0.035714300000000004	3.5694826544599296
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.035714300000000004	3.5694826544599296
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	3.5694826544599296
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0338384	3.3819949391329764
AICARDI SYNDROME; AIC	0.0328502	3.2832288213835796
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.032803653999999995	3.278576759334638
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	3.278576759334638
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0322581	3.224051106022905
DEND SYNDROME	0.0322581	3.224051106022905
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	3.224051106022905
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.0322581	3.224051106022905
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	3.224051106022905
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0322581	3.224051106022905
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	3.224051106022905
DENT DISEASE	0.0322581	3.224051106022905
COG1-CDG	0.0322581	3.224051106022905
MILD CANAVAN DISEASE	0.0322581	3.224051106022905
DYSTONIA, JUVENILE-ONSET	0.0322581	3.224051106022905
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0322581	3.224051106022905
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	3.224051106022905
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	3.224051106022905
MEIER-GORLIN SYNDROME 5; MGORS5	0.0322581	3.224051106022905
ISOTRETINOIN-LIKE SYNDROME	0.0322581	3.224051106022905
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	3.224051106022905
CONGENITAL ANALBUMINEMIA	0.0322581	3.224051106022905
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.02967174	2.9655561289916044
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.029292899999999997	2.9276927854901045
COFFIN-SIRIS SYNDROME 1; CSS1	0.029229094	2.92131566455394
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.02914651	2.9130617675004933
GAPO SYNDROME	0.02868354	2.866790011242207
15Q13.3 MICRODELETION SYNDROME	0.028323354000000002	2.8307910506191707
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	2.8307910506191707
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	2.8307910506191707
NON-DISTAL TRISOMY 13Q	0.02791194	2.7896720832363022
BUSCHKE-OLLENDORFF SYNDROME	0.02791194	2.7896720832363022
CYANIDE, INABILITY TO SMELL	0.027777800000000002	2.776265397307438
MENKES DISEASE	0.027777800000000002	2.776265397307438
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	2.776265397307438
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	2.776265397307438
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	2.776265397307438
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	2.776265397307438
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	2.776265397307438
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	2.776265397307438
OROFACIAL CLEFT 3	0.027777800000000002	2.776265397307438
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	2.776265397307438
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	2.776265397307438
CLEFT CHIN	0.027777800000000002	2.776265397307438
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	2.776265397307438
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	2.776265397307438
DIMPLES, FACIAL	0.027777800000000002	2.776265397307438
DWARFISM, LEVI TYPE	0.027777800000000002	2.776265397307438
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	2.776265397307438
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	2.776265397307438
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	2.776265397307438
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	2.776265397307438
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	2.776265397307438
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	2.776265397307438
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	2.776265397307438
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	2.776265397307438
NASAL BONES, ABSENCE OF	0.027777800000000002	2.776265397307438
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	2.776265397307438
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	2.776265397307438
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	2.776265397307438
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0277778	2.7762653973074376
AMELO-ONYCHO-HYPOHIDROTIC SYNDROME	0.025126239999999998	2.511253975348733
OCULOCEREBRORENAL SYNDROME OF LOWE	0.025126239999999998	2.511253975348733
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.025126239999999998	2.511253975348733
LARON SYNDROME	0.025126239999999998	2.511253975348733
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.025126239999999998	2.511253975348733
HENNEKAM SYNDROME	0.025126239999999998	2.511253975348733
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.02341424	2.3401473232672023
FANCONI ANEMIA	0.023272854	2.3260164324312216
POTOCKI-LUPSKI SYNDROME	0.023272854	2.3260164324312216
COWDEN SYNDROME	0.023272854	2.3260164324312216
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.023272854	2.3260164324312216
MAN1B1-CDG	0.023272854	2.3260164324312216
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.023272854	2.3260164324312216
KAGAMI-OGATA SYNDROME	0.023272854	2.3260164324312216
16P11.2P12.2 MICRODELETION SYNDROME	0.023272854	2.3260164324312216
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.023272854	2.3260164324312216
CARDIOFACIOCUTANEOUS SYNDROME	0.023272854	2.3260164324312216
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.023272854	2.3260164324312216
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	2.2714907791194885
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.0227273	2.2714907791194885
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	2.2714907791194885
SIRENOMELIA	0.0227273	2.2714907791194885
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.0227273	2.2714907791194885
JUVENILE XANTHOGRANULOMA	0.0227273	2.2714907791194885
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	2.2714907791194885
HYPOADRENOCORTICISM, FAMILIAL	0.0227273	2.2714907791194885
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.0227273	2.2714907791194885
NEUROFIBROMATOSIS, TYPE I	0.0227273	2.2714907791194885
ARTERIES, ANOMALIES OF	0.0227273	2.2714907791194885
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.0227273	2.2714907791194885
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.0227273	2.2714907791194885
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	2.2714907791194885
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0227273	2.2714907791194885
THUMB DEFORMITY	0.0227273	2.2714907791194885
RHOMBENCEPHALOSYNAPSIS	0.0227273	2.2714907791194885
EPIDERMODYSPLASIA VERRUCIFORMIS	0.0227273	2.2714907791194885
PEELING SKIN SYNDROME	0.0227273	2.2714907791194885
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.0227273	2.2714907791194885
FATCO SYNDROME	0.0227273	2.2714907791194885
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.0227273	2.2714907791194885
BETHLEM MYOPATHY 1	0.0227273	2.2714907791194885
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	2.2714907791194885
GASTROCUTANEOUS SYNDROME	0.0227273	2.2714907791194885
MILLER-DIEKER SYNDROME	0.0227273	2.2714907791194885
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	2.2714907791194885
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	2.2714907791194885
114030 CAFE-AU-LAIT SPOTS, MULTIPLE	0.0227273	2.2714907791194885
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.0227273	2.2714907791194885
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.0227273	2.2714907791194885
LARSEN SYNDROME	0.0227273	2.2714907791194885
CUTANEOUS MASTOCYTOSIS	0.0227273	2.2714907791194885
NEUROFIBROMATOSIS TYPE 6	0.0227273	2.2714907791194885
CONGENITAL ATRANSFERRINEMIA	0.0227273	2.2714907791194885
JOHNSON NEUROECTODERMAL SYNDROME	0.0227273	2.2714907791194885
COCAINE EMBRYOFETOPATHY	0.0227273	2.2714907791194885
AMYLOIDOSIS	0.0227273	2.2714907791194885
LIMB-MAMMARY SYNDROME	0.0227273	2.2714907791194885
MUSCULAR HYPERTONIA, LETHAL	0.0227273	2.2714907791194885
NEUROFIBROMATOSIS TYPE 2	0.0227273	2.2714907791194885
NEUROFIBROMATOSIS TYPE 1	0.0227273	2.2714907791194885
PREPAPILLARY VASCULAR LOOPS	0.0227273	2.2714907791194885
HYPERKERATOSIS-HYPERPIGMENTATION SYNDROME	0.0227273	2.2714907791194885
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0227273	2.2714907791194885
COWDEN SYNDROME 5; CWS5	0.0227273	2.2714907791194885
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.0227273	2.2714907791194885
COWDEN SYNDROME 6; CWS6	0.0227273	2.2714907791194885
ACRORENAL-MANDIBULAR SYNDROME	0.0227273	2.2714907791194885
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	2.2714907791194885
ATROPHODERMA VERMICULATA; AVA	0.0227273	2.2714907791194885
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.0227273	2.2714907791194885
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	2.2714907791194885
MCCUNE-ALBRIGHT SYNDROME	0.0227273	2.2714907791194885
OCULOFACIOCARDIODENTAL SYNDROME	0.022415393999999998	2.24031718599791
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.022415393999999998	2.24031718599791
WOLF-HIRSCHHORN SYNDROME	0.022284654	2.2272503146818243
11Q22.2Q22.3 MICRODELETION SYNDROME	0.022284654	2.2272503146818243
RING CHROMOSOME 12 SYNDROME	0.022284654	2.2272503146818243
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.021869839999999998	2.185791532686177
FOCAL DERMAL HYPOPLASIA; FDH	0.021869839999999998	2.185791532686177
DYSOSTEOSCLEROSIS	0.021869839999999998	2.185791532686177
JOHANSON-BLIZZARD SYNDROME	0.021869839999999998	2.185791532686177
BRACHYDACTYLY, TYPE E2; BDE2	0.021869839999999998	2.185791532686177
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.021869839999999998	2.185791532686177
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.021869839999999998	2.185791532686177
PRIMARY MYELOFIBROSIS	0.0217391	2.1727246613700912
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.0217391	2.1727246613700912
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.0217391	2.1727246613700912
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.0217391	2.1727246613700912
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.0217391	2.1727246613700912
ENCHONDROMATOSIS, MULTIPLE	0.0217391	2.1727246613700912
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.0217391	2.1727246613700912
OMODYSPLASIA 1; OMOD1	0.0217391	2.1727246613700912
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.0217391	2.1727246613700912
LUMBAR SYNDROME	0.0217391	2.1727246613700912
VERRUCOUS HEMANGIOMA	0.0217391	2.1727246613700912
JUVENILE POLYPOSIS OF INFANCY	0.0217391	2.1727246613700912
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.0217391	2.1727246613700912
MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE	0.0217391	2.1727246613700912
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.0217391	2.1727246613700912
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.0217391	2.1727246613700912
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.0217391	2.1727246613700912
LYMPHATIC MALFORMATION 1	0.0217391	2.1727246613700912
KAPOSI SARCOMA	0.0217391	2.1727246613700912
TEMPI SYNDROME	0.0217391	2.1727246613700912
KLIPPEL-TRÉNAUNAY SYNDROME	0.0217391	2.1727246613700912
POEMS SYNDROME	0.0217391	2.1727246613700912
MICROFORM HOLOPROSENCEPHALY	0.0217391	2.1727246613700912
PTEN HAMARTOMA TUMOR SYNDROME	0.0217391	2.1727246613700912
PROTEUS-LIKE SYNDROME	0.0217391	2.1727246613700912
COWDEN SYNDROME 7; CWS7	0.0217391	2.1727246613700912
PROTEUS SYNDROME	0.0217391	2.1727246613700912
ACROCEPHALOSYNDACTYLY	0.0217391	2.1727246613700912
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.021650339999999997	2.163853501067079
KABUKI SYNDROME 1	0.021424294	2.1412612263729076
HOLOPROSENCEPHALY	0.018727353999999998	1.87171427878835
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.018727353999999998	1.87171427878835
COHEN SYNDROME	0.018727353999999998	1.87171427878835
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.018727353999999998	1.87171427878835
TREACHER-COLLINS SYNDROME	0.018727353999999998	1.87171427878835
EEC SYNDROME	0.018181799999999998	1.8171886254766167
CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK	0.018181799999999998	1.8171886254766167
FOCAL DERMAL HYPOPLASIA	0.018181799999999998	1.8171886254766167
CHARLIE M SYNDROME	0.018181799999999998	1.8171886254766167
CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA	0.018181799999999998	1.8171886254766167
DENTAL ANKYLOSIS	0.018181799999999998	1.8171886254766167
STICKLER SYNDROME	0.018181799999999998	1.8171886254766167
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.018181799999999998	1.8171886254766167
ANKYLOBLEPHARON FILIFORME ADNATUM-IMPERFORATE ANUS SYNDROME	0.018181799999999998	1.8171886254766167
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.018181799999999998	1.8171886254766167
OSTEOGLOSPHONIC DYSPLASIA	0.018181799999999998	1.8171886254766167
BLOOM SYNDROME	0.018181799999999998	1.8171886254766167
MAXILLONASAL DYSPLASIA	0.018181799999999998	1.8171886254766167
DYSOSTOSIS, STANESCU TYPE	0.018181799999999998	1.8171886254766167
PAPILLON-LEFÈVRE SYNDROME	0.018181799999999998	1.8171886254766167
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.018181799999999998	1.8171886254766167
CLASSICAL EHLERS-DANLOS SYNDROME	0.018181799999999998	1.8171886254766167
DERMOODONTODYSPLASIA	0.018181799999999998	1.8171886254766167
PROGEROID SYNDROME, PETTY TYPE	0.018181799999999998	1.8171886254766167
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.018181799999999998	1.8171886254766167
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.018181799999999998	1.8171886254766167
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.018181799999999998	1.8171886254766167
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.018181799999999998	1.8171886254766167
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.018181799999999998	1.8171886254766167
FRONTOMETAPHYSEAL DYSPLASIA	0.018181799999999998	1.8171886254766167
TOOTH AGENESIS, SELECTIVE, 4	0.018181799999999998	1.8171886254766167
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.018181799999999998	1.8171886254766167
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.018181799999999998	1.8171886254766167
KALLMANN SYNDROME	0.018181799999999998	1.8171886254766167
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.018181799999999998	1.8171886254766167
ODONTO-ONYCHO DYSPLASIA-ALOPECIA SYNDROME	0.018181799999999998	1.8171886254766167
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.018181799999999998	1.8171886254766167
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.018181799999999998	1.8171886254766167
PYCNODYSOSTOSIS	0.018055540000000002	1.8045695098856043
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.018055540000000002	1.8045695098856043
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.018055540000000002	1.8045695098856043
SHORT SYNDROME	0.018055540000000002	1.8045695098856043
SCALP-EAR-NIPPLE SYNDROME	0.018055540000000002	1.8045695098856043
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.01728394	1.7274515818796996
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.7231999014009913
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	1.7231999014009913
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.7231999014009913
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.7231999014009913
ALCOHOL DEPENDENCE	0.0172414	1.7231999014009913
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.7231999014009913
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.7231999014009913
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.7231999014009913
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	1.7231999014009913
ENDOCARDIAL FIBROELASTOSIS	0.0172414	1.7231999014009913
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	1.7231999014009913
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.7231999014009913
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	1.7231999014009913
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.7231999014009913
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.7231999014009913
TRANSSEXUALITY	0.0172414	1.7231999014009913
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	1.7231999014009913
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	1.7231999014009913
THUMBS, CONGENITAL CLASPED	0.0172414	1.7231999014009913
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.7231999014009913
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.7231999014009913
ERYTHERMALGIA, PRIMARY	0.0172414	1.7231999014009913
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.7231999014009913
CARDIAC ARRHYTHMIA	0.0172414	1.7231999014009913
CERVICAL RIB	0.0172414	1.7231999014009913
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	1.7231999014009913
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.7231999014009913
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	1.7231999014009913
DIASTEMATOMYELIA	0.0172414	1.7231999014009913
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	1.7231999014009913
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	1.7231999014009913
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.7231999014009913
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.7231999014009913
SICKLE CELL ANEMIA	0.0172414	1.7231999014009913
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.7231999014009913
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.7231999014009913
MYOPATHY, CONGENITAL	0.0172414	1.7231999014009913
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	1.7231999014009913
RHEUMATOID ARTHRITIS	0.0172414	1.7231999014009913
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	1.7231999014009913
MOSAIC TRISOMY 15	0.0172414	1.7231999014009913
PALMOMENTAL REFLEX	0.0172414	1.7231999014009913
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	1.7231999014009913
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.7231999014009913
JUMPING FRENCHMAN OF MAINE	0.0172414	1.7231999014009913
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.7231999014009913
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.7231999014009913
269800 SENILE PLAQUE FORMATION	0.0172414	1.7231999014009913
MOTION SICKNESS	0.0172414	1.7231999014009913
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	1.7231999014009913
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.7231999014009913
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.017212254	1.7202868906056827
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.017212254	1.7202868906056827
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.017212254	1.7202868906056827
HOYERAAL-HREIDARSSON SYNDROME	0.017212254	1.7202868906056827
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.017212254	1.7202868906056827
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.017212254	1.7202868906056827
ADAMANTINOMA OF LONG BONES	0.0166667	1.6657612372939494
117600 CEREBRAL SARCOMA	0.0166667	1.6657612372939494
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.0166667	1.6657612372939494
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0166667	1.6657612372939494
HEPATOCELLULAR CARCINOMA	0.0166667	1.6657612372939494
NASOPHARYNGEAL CARCINOMA	0.0166667	1.6657612372939494
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.0166667	1.6657612372939494
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0166667	1.6657612372939494
HURIEZ SYNDROME; HRZ	0.0166667	1.6657612372939494
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.0166667	1.6657612372939494
N SYNDROME	0.0166667	1.6657612372939494
ACQUIRED PURPURA FULMINANS	0.0166667	1.6657612372939494
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.0166667	1.6657612372939494
INTESTINAL LYMPHANGIECTASIA	0.0166667	1.6657612372939494
MALIGNANT PERITONEAL MESOTHELIOMA	0.0166667	1.6657612372939494
ANTISYNTHETASE SYNDROME	0.0166667	1.6657612372939494
BUTYRYLCHOLINESTERASE DEFICIENCY	0.0166667	1.6657612372939494
CHYLOUS ASCITES	0.0166667	1.6657612372939494
CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	0.0166667	1.6657612372939494
PAGET DISEASE, EXTRAMAMMARY	0.0166667	1.6657612372939494
TRIGEMINAL NEURALGIA	0.0166667	1.6657612372939494
GORLIN SYNDROME	0.0166667	1.6657612372939494
PRIMARY PERITONEAL CARCINOMA	0.0166667	1.6657612372939494
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.0166667	1.6657612372939494
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0166667	1.6657612372939494
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.0166667	1.6657612372939494
ANDROGEN INSENSITIVITY SYNDROME	0.0166667	1.6657612372939494
BROOKE-SPIEGLER SYNDROME; BSS	0.0166667	1.6657612372939494
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0166667	1.6657612372939494
ICHTHYOSIS, X-LINKED	0.0166667	1.6657612372939494
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.0166667	1.6657612372939494
PERITONEAL CYSTIC MESOTHELIOMA	0.0166667	1.6657612372939494
THYMOMA, FAMILIAL	0.0166667	1.6657612372939494
AASE-SMITH SYNDROME	0.0166667	1.6657612372939494
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.0166667	1.6657612372939494
X-LINKED AGAMMAGLOBULINEMIA	0.0166667	1.6657612372939494
ONCOCYTOMA	0.0166667	1.6657612372939494
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.0166667	1.6657612372939494
CHOROIDAL OSTEOMA, BILATERAL	0.0166667	1.6657612372939494
EPIDERMOLYSIS BULLOSA SIMPLEX	0.0166667	1.6657612372939494
AYMÉ-GRIPP SYNDROME	0.015470953999999999	1.5462518361257942
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.015470953999999999	1.5462518361257942
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.015470953999999999	1.5462518361257942
GLASS SYNDROME	0.015470953999999999	1.5462518361257942
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.015470953999999999	1.5462518361257942
AU-KLINE SYNDROME; AUKS	0.015470953999999999	1.5462518361257942
KBG SYNDROME	0.015470953999999999	1.5462518361257942
KBG SYNDROME	0.015470953999999999	1.5462518361257942
OCULOSKELETODENTAL SYNDROME; OCSKD	0.015470953999999999	1.5462518361257942
2Q32Q33 MICRODELETION SYNDROME	0.015470953999999999	1.5462518361257942
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.015470953999999999	1.5462518361257942
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.015470953999999999	1.5462518361257942
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.015470953999999999	1.5462518361257942
ZECHI-CEIDE SYNDROME	0.015470953999999999	1.5462518361257942
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.015470953999999999	1.5462518361257942
OTOPALATODIGITAL SYNDROME TYPE 2	0.015470953999999999	1.5462518361257942
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.015251454	1.5243138045066962
2Q23.1 MICRODUPLICATION SYNDROME	0.015251454	1.5243138045066962
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.015251454	1.5243138045066962
SYNDROMIC DIARRHEA	0.015251454	1.5243138045066962
19P13.13 MICRODELETION SYNDROME	0.015251454	1.5243138045066962
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.015251454	1.5243138045066962
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.015251454	1.5243138045066962
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.015251454	1.5243138045066962
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.015251454	1.5243138045066962
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.015251454	1.5243138045066962
WITTEVEEN-KOLK SYNDROME	0.015251454	1.5243138045066962
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.015251454	1.5243138045066962
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.015251454	1.5243138045066962
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.015251454	1.5243138045066962
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.015251454	1.5243138045066962
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.015251454	1.5243138045066962
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.015251454	1.5243138045066962
NOONAN SYNDROME 6; NS6	0.015251454	1.5243138045066962
OTOPALATODIGITAL SYNDROME TYPE 1	0.014925399999999998	1.491726182814061
CHERUBISM	0.014925399999999998	1.491726182814061
DEAFNESS-OLIGODONTIA SYNDROME	0.014925399999999998	1.491726182814061
NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	0.014925399999999998	1.491726182814061
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.014925399999999998	1.491726182814061
OLIGODONTIA	0.014925399999999998	1.491726182814061
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.014925399999999998	1.491726182814061
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.014925399999999998	1.491726182814061
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.014925399999999998	1.491726182814061
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.014925399999999998	1.491726182814061
13Q12.3 MICRODELETION SYNDROME	0.014925399999999998	1.491726182814061
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.014925399999999998	1.491726182814061
FONTAINE PROGEROID SYNDROME; FPS	0.014925399999999998	1.491726182814061
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.014925399999999998	1.491726182814061
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.014925399999999998	1.491726182814061
TEETH, CONGENITAL ABSENCE OF, WITH TAURODONTIA AND SPARSE HAIR	0.014925399999999998	1.491726182814061
ZECHI-CEIDE SYNDROME	0.014925399999999998	1.491726182814061
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.014925399999999998	1.491726182814061
%613857 OROFACIAL CLEFT 13; OFC13	0.014925399999999998	1.491726182814061
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.014925399999999998	1.491726182814061
DEAFNESS-OLIGODONTIA SYNDROME	0.014925399999999998	1.491726182814061
SECKEL SYNDROME 5; SCKL5	0.014925399999999998	1.491726182814061
CHERUBISM	0.014925399999999998	1.491726182814061
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.014925399999999998	1.491726182814061
GORLIN-CHAUDHRY-MOSS SYNDROME	0.014925399999999998	1.491726182814061
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.014925399999999998	1.491726182814061
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.014925399999999998	1.491726182814061
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.014925399999999998	1.491726182814061
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.014925399999999998	1.491726182814061
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.014925399999999998	1.491726182814061
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.014925399999999998	1.491726182814061
TOOTH AGENESIS, SELECTIVE, X-LINKED, 1	0.014925399999999998	1.491726182814061
TEEBI-SHALTOUT SYNDROME; TBSH	0.014925399999999998	1.491726182814061
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.014925399999999998	1.491726182814061
TUBEROUS SCLEROSIS 2; TSC2	0.0147059	1.469788151194963
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.0147059	1.469788151194963
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.0147059	1.469788151194963
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.0147059	1.469788151194963
CARNEY COMPLEX	0.0147059	1.469788151194963
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.0147059	1.469788151194963
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0147059	1.469788151194963
SMITH-KINGSMORE SYNDROME; SKS	0.0147059	1.469788151194963
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.0147059	1.469788151194963
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.0147059	1.469788151194963
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0147059	1.469788151194963
LEGIUS SYNDROME	0.0147059	1.469788151194963
NF1-MICRODELETION SYNDROME	0.0147059	1.469788151194963
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.0147059	1.469788151194963
HYPERPIGMENTATION, FAMILIAL PROGRESSIVE	0.0147059	1.469788151194963
BLOOM SYNDROME	0.0147059	1.469788151194963
FANCONI ANEMIA	0.0147059	1.469788151194963
7Q11.23 MICRODUPLICATION SYNDROME	0.0147059	1.469788151194963
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.0147059	1.469788151194963
NIJMEGEN BREAKAGE SYNDROME	0.0147059	1.469788151194963
GASTROCUTANEOUS SYNDROME	0.0147059	1.469788151194963
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.0147059	1.469788151194963
RING CHROMOSOME 13 SYNDROME	0.0147059	1.469788151194963
TUBEROUS SCLEROSIS-1	0.0147059	1.469788151194963
NEUROFIBROMATOSIS, TYPE II	0.0147059	1.469788151194963
RUSSELL-SILVER SYNDROME, X-LINKED	0.0147059	1.469788151194963
CENTRAL PRECOCIOUS PUBERTY	0.0147059	1.469788151194963
TURCOT SYNDROME WITH POLYPOSIS	0.0147059	1.469788151194963
HALL-RIGGS SYNDROME	0.01435185	1.4344024560025181
TEMPLE-BARAITSER SYNDROME	0.01435185	1.4344024560025181
COFFIN-LOWRY SYNDROME	0.01435185	1.4344024560025181
KID SYNDROME	0.01435185	1.4344024560025181
GABRIELE-DE VRIES SYNDROME	0.013580249999999999	1.3572845279966135
4Q21 MICRODELETION SYNDROME	0.013580249999999999	1.3572845279966135
TRISOMY 13	0.013580249999999999	1.3572845279966135
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.013580249999999999	1.3572845279966135
CURRY-JONES SYNDROME	0.011656654	1.1650298133252213
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.011656654	1.1650298133252213
131600 EPIDERMOID CYSTS	0.0111111	1.1105041600134882
SIMOSA CRANIOFACIAL SYNDROME	0.0111111	1.1105041600134882
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	1.1105041600134882
PIGMENTED PURPURIC ERUPTION	0.0111111	1.1105041600134882
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0111111	1.1105041600134882
SAY SYNDROME	0.0111111	1.1105041600134882
LATERAL MENINGOCELE SYNDROME	0.0111111	1.1105041600134882
PSEUDOATROPHODERMA COLLI	0.0111111	1.1105041600134882
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	1.1105041600134882
SYRINGOMAS, MULTIPLE	0.0111111	1.1105041600134882
PILONIDAL SINUS	0.0111111	1.1105041600134882
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.0111111	1.1105041600134882
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0111111	1.1105041600134882
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	1.1105041600134882
FUTCHER LINE	0.0111111	1.1105041600134882
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	1.1105041600134882
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	1.1105041600134882
KYRLE DISEASE	0.0111111	1.1105041600134882
LENTIGINES	0.0111111	1.1105041600134882
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	1.1105041600134882
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.0111111	1.1105041600134882
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0111111	1.1105041600134882
LICHEN PLANUS, FAMILIAL	0.0111111	1.1105041600134882
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0111111	1.1105041600134882
MARFANOID HYPERMOBILITY SYNDROME	0.0111111	1.1105041600134882
TRICHILEMMAL CYST 1	0.0111111	1.1105041600134882
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	1.1105041600134882
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0111111	1.1105041600134882
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0111111	1.1105041600134882
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0111111	1.1105041600134882
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	1.1105041600134882
HYPOPLASMINOGENEMIA	0.0111111	1.1105041600134882
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	1.1105041600134882
GLOMUVENOUS MALFORMATIONS	0.0111111	1.1105041600134882
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.0111111	1.1105041600134882
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	1.1105041600134882
PATELLA APLASIA-HYPOPLASIA	0.0111111	1.1105041600134882
TYROSINE TRANSAMINASE DEFICIENCY	0.0111111	1.1105041600134882
KERATOSIS, FAMILIAL ACTINIC	0.0111111	1.1105041600134882
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	1.1105041600134882
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	1.1105041600134882
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0111111	1.1105041600134882
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	1.1105041600134882
PARANA HARD-SKIN SYNDROME	0.0111111	1.1105041600134882
CAROTENEMIA, FAMILIAL	0.0111111	1.1105041600134882
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.0111111	1.1105041600134882
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.0111111	1.1105041600134882
FASCIAL DYSTROPHY, CONGENITAL	0.0111111	1.1105041600134882
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	1.1105041600134882
CAMOS SYNDROME	0.0111111	1.1105041600134882
TRIOPIA	0.0111111	1.1105041600134882
MUCOPOLYSACCHARIDOSIS TYPE IX	0.0111111	1.1105041600134882
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.0111111	1.1105041600134882
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	1.1105041600134882
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	1.1105041600134882
ACROMIAL DIMPLES	0.0111111	1.1105041600134882
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.0111111	1.1105041600134882
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.0111111	1.1105041600134882
GM1 GANGLIOSIDOSIS	0.0111111	1.1105041600134882
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	1.1105041600134882
PRENATAL BOWING	0.0111111	1.1105041600134882
DERMATOSIS PAPULOSA NIGRA	0.0111111	1.1105041600134882
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	1.1105041600134882
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	1.1105041600134882
CIRCUMVALLATE PLACENTA SYNDROME	0.0111111	1.1105041600134882
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0111111	1.1105041600134882
POLYVALVULAR HEART DISEASE SYNDROME	0.0111111	1.1105041600134882
DERMAL RIDGES, PATTERNLESS	0.0111111	1.1105041600134882
ADENYLOSUCCINASE DEFICIENCY	0.007952964	0.7948627594421354
WEBB-DATTANI SYNDROME; WEDAS	0.007952964	0.7948627594421354
300270 ADRENOMYODYSTROPHY	0.007952964	0.7948627594421354
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.007952964	0.7948627594421354
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.7948627594421354
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.007952964	0.7948627594421354
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.7948627594421354
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.007952964	0.7948627594421354
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.7948627594421354
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.007952964	0.7948627594421354
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.007952964	0.7948627594421354
PIERPONT SYNDROME	0.007952964	0.7948627594421354
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.007952964	0.7948627594421354
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.007952964	0.7948627594421354
GENITOPATELLAR SYNDROME	0.007489994	0.7485910031838491
SULFOCYSTEINURIA	0.007489994	0.7485910031838491
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.007489994	0.7485910031838491
EMANUEL SYNDROME	0.007489994	0.7485910031838491
KLEEFSTRA SYNDROME	0.007489994	0.7485910031838491
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.007489994	0.7485910031838491
ELSAHY-WATERS SYNDROME; ESWS	0.007489994	0.7485910031838491
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.007489994	0.7485910031838491
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007489994	0.7485910031838491
DE BARSY SYNDROME	0.007489994	0.7485910031838491
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.007489994	0.7485910031838491
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.007489994	0.7485910031838491
WRINKLY SKIN SYNDROME	0.007489994	0.7485910031838491
48,XXXY SYNDROME	0.007489994	0.7485910031838491
INCONTINENTIA PIGMENTI	0.007489994	0.7485910031838491
MONOSOMY 9Q22.3	0.007489994	0.7485910031838491
COLE-CARPENTER SYNDROME	0.007489994	0.7485910031838491
49,XXXXY SYNDROME	0.007489994	0.7485910031838491
LOWRY-MACLEAN SYNDROME	0.007489994	0.7485910031838491
CODAS SYNDROME	0.007489994	0.7485910031838491
CODAS SYNDROME	0.007489994	0.7485910031838491
CHARGE SYNDROME	0.007489994	0.7485910031838491
GENITOPATELLAR SYNDROME; GTPTS	0.007489994	0.7485910031838491
AARSKOG-SCOTT SYNDROME	0.007489994	0.7485910031838491
48,XXYY SYNDROME	0.007489994	0.7485910031838491
DPM1-CDG	0.00740741	0.7403371061304022
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00740741	0.7403371061304022
PITT-HOPKINS-LIKE SYNDROME	0.00740741	0.7403371061304022
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.7403371061304022
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00740741	0.7403371061304022
COFS SYNDROME	0.00740741	0.7403371061304022
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.00740741	0.7403371061304022
CONO-SPONDYLAR DYSPLASIA	0.00740741	0.7403371061304022
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00740741	0.7403371061304022
HENNEKAM-BEEMER SYNDROME	0.00740741	0.7403371061304022
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00740741	0.7403371061304022
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00740741	0.7403371061304022
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.00740741	0.7403371061304022
KEPPEN-LUBINSKY SYNDROME	0.00740741	0.7403371061304022
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.7403371061304022
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00740741	0.7403371061304022
CHRISTIANSON SYNDROME	0.00740741	0.7403371061304022
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00740741	0.7403371061304022
MEHMO SYNDROME	0.00740741	0.7403371061304022
FRYNS SYNDROME	0.00740741	0.7403371061304022
MONOSOMY 5P	0.00740741	0.7403371061304022
MUCOLIPIDOSIS TYPE II	0.00740741	0.7403371061304022
NEONATAL ADRENOLEUKODYSTROPHY	0.00740741	0.7403371061304022
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.00740741	0.7403371061304022
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00740741	0.7403371061304022
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00740741	0.7403371061304022
CRANIOFACIAL DYSSYNOSTOSIS	0.00740741	0.7403371061304022
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.7403371061304022
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.00740741	0.7403371061304022
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00740741	0.7403371061304022
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00740741	0.7403371061304022
CROME SYNDROME	0.00740741	0.7403371061304022
BOWEN-CONRADI SYNDROME	0.00740741	0.7403371061304022
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.00740741	0.7403371061304022
YUNIS-VARON SYNDROME	0.00740741	0.7403371061304022
COG8-CDG	0.00740741	0.7403371061304022
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00740741	0.7403371061304022
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.7403371061304022
WARBURG MICRO SYNDROME 2; WARBM2	0.00740741	0.7403371061304022
HEREDITARY METHEMOGLOBINEMIA	0.00740741	0.7403371061304022
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00740741	0.7403371061304022
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.00740741	0.7403371061304022
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00740741	0.7403371061304022
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00740741	0.7403371061304022
1Q41Q42 MICRODELETION SYNDROME	0.00740741	0.7403371061304022
SECKEL SYNDROME 7; SCKL7	0.00740741	0.7403371061304022
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00740741	0.7403371061304022
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00740741	0.7403371061304022
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.7403371061304022
LOWRY-MACLEAN SYNDROME	0.00740741	0.7403371061304022
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.00740741	0.7403371061304022
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00740741	0.7403371061304022
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00740741	0.7403371061304022
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.7403371061304022
UNILATERAL POLYMICROGYRIA	0.00740741	0.7403371061304022
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00740741	0.7403371061304022
SMITH-FINEMAN-MYERS SYNDROME	0.00740741	0.7403371061304022
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00740741	0.7403371061304022
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.7403371061304022
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00740741	0.7403371061304022
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.00740741	0.7403371061304022
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00740741	0.7403371061304022
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00740741	0.7403371061304022
AMISH LETHAL MICROCEPHALY	0.00740741	0.7403371061304022
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.00740741	0.7403371061304022
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.00740741	0.7403371061304022
TRISOMY XQ28	0.00740741	0.7403371061304022
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00740741	0.7403371061304022
DISTAL MONOSOMY 10P	0.00740741	0.7403371061304022
ADRENOMYODYSTROPHY	0.00740741	0.7403371061304022
ADENYLOSUCCINATE LYASE DEFICIENCY	0.00740741	0.7403371061304022
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.00740741	0.7403371061304022
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.00740741	0.7403371061304022
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00740741	0.7403371061304022
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00740741	0.7403371061304022
2Q24 MICRODELETION SYNDROME	0.00740741	0.7403371061304022
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.7403371061304022
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.7403371061304022
QAZI-MARKOUIZOS SYNDROME	0.00740741	0.7403371061304022
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00740741	0.7403371061304022
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00740741	0.7403371061304022
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.7403371061304022
LISSENCEPHALY 5; LIS5	0.00740741	0.7403371061304022
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.7403371061304022
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.7403371061304022
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.7403371061304022
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00740741	0.7403371061304022
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.00740741	0.7403371061304022
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00740741	0.7403371061304022
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.7403371061304022
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00740741	0.7403371061304022
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.7403371061304022
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00740741	0.7403371061304022
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00740741	0.7403371061304022
BARBER-SAY SYNDROME; BBRSAY	0.00694444	0.6940653498721159
DYSOSTEOSCLEROSIS	0.00694444	0.6940653498721159
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00694444	0.6940653498721159
INCONTINENTIA PIGMENTI; IP	0.00694444	0.6940653498721159
MELNICK-NEEDLES SYNDROME	0.00694444	0.6940653498721159
DUBOWITZ SYNDROME	0.00694444	0.6940653498721159
CLEIDOCRANIAL DYSPLASIA	0.00694444	0.6940653498721159
ODONTOCHONDRODYSPLASIA	0.00694444	0.6940653498721159
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00694444	0.6940653498721159
RAMON SYNDROME	0.00694444	0.6940653498721159
CORNELIA DE LANGE SYNDROME 1	0.00694444	0.6940653498721159
TETRASOMY 12P	0.00694444	0.6940653498721159
PYLE DISEASE; PYL	0.00694444	0.6940653498721159
ELLIS-VAN CREVELD SYNDROME	0.00694444	0.6940653498721159
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00694444	0.6940653498721159
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.00694444	0.6940653498721159
MELNICK-NEEDLES SYNDROME	0.00694444	0.6940653498721159
APERT SYNDROME	0.00694444	0.6940653498721159
MICROPHTHALMIA, LENZ TYPE	0.00694444	0.6940653498721159
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00694444	0.6940653498721159
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00694444	0.6940653498721159
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00694444	0.6940653498721159
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.00694444	0.6940653498721159
CHST3-RELATED SKELETAL DYSPLASIA	0.00694444	0.6940653498721159
MOMO SYNDROME	0.00694444	0.6940653498721159
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00694444	0.6940653498721159
FRANK-TER HAAR SYNDROME	0.00694444	0.6940653498721159
3M SYNDROME	0.00694444	0.6940653498721159
ACRODYSOSTOSIS	0.00694444	0.6940653498721159
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00694444	0.6940653498721159
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.00694444	0.6940653498721159
FAMILIAL ADENOMATOUS POLYPOSIS	0.00694444	0.6940653498721159
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00694444	0.6940653498721159
BARBER-SAY SYNDROME	0.00694444	0.6940653498721159
MUCOPOLYSACCHARIDOSIS, TYPE II	0.00694444	0.6940653498721159
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00694444	0.6940653498721159
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00694444	0.6940653498721159
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.00694444	0.6940653498721159
ODONTOCHONDRODYSPLASIA; ODCD	0.00694444	0.6940653498721159
THREE M SYNDROME 2; 3M2	0.00694444	0.6940653498721159
SPONDYLOENCHONDRODYSPLASIA	0.00694444	0.6940653498721159
COCKAYNE SYNDROME	0.00694444	0.6940653498721159
ACROOTOOCULAR SYNDROME	0.00694444	0.6940653498721159
HYPOPHOSPHATEMIC RICKETS	0.00694444	0.6940653498721159
NON-ERUPTION OF TEETH-MAXILLARY HYPOPLASIA-GENU VALGUM SYNDROME	0.00694444	0.6940653498721159
IMMUNODEFICIENCY 33	0.00694444	0.6940653498721159
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00694444	0.6940653498721159
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00694444	0.6940653498721159
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00694444	0.6940653498721159
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00694444	0.6940653498721159
MOWAT-WILSON SYNDROME; MOWS	0.00694444	0.6940653498721159
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00694444	0.6940653498721159
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00694444	0.6940653498721159
ENAMEL-RENAL SYNDROME	0.00694444	0.6940653498721159
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00694444	0.6940653498721159
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00694444	0.6940653498721159
ZIMMERMANN-LABAND SYNDROME 1	0.00694444	0.6940653498721159
CORNELIA DE LANGE SYNDROME	0.00694444	0.6940653498721159
ELLIS VAN CREVELD SYNDROME	0.00694444	0.6940653498721159
OTODENTAL SYNDROME	0.00694444	0.6940653498721159
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00694444	0.6940653498721159
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00694444	0.6940653498721159
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00694444	0.6940653498721159
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00694444	0.6940653498721159
RAMON SYNDROME	0.00694444	0.6940653498721159
FRONTOMETAPHYSEAL DYSPLASIA	0.00694444	0.6940653498721159
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00694444	0.6940653498721159
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.00694444	0.6940653498721159
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.00694444	0.6940653498721159
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.00694444	0.6940653498721159
CAMURATI-ENGELMANN DISEASE	0.00694444	0.6940653498721159
PALLISTER-KILLIAN SYNDROME	0.00694444	0.6940653498721159
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00694444	0.6940653498721159
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00694444	0.6940653498721159
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00694444	0.6940653498721159
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.00694444	0.6940653498721159
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.006718394	0.6714730751779444
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.006718394	0.6714730751779444
HOLMES-GANG SYNDROME	0.006718394	0.6714730751779444
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.006718394	0.6714730751779444
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.006718394	0.6714730751779444
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.006718394	0.6714730751779444
OROFACIODIGITAL SYNDROME IX; OFD9	0.006718394	0.6714730751779444
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.006718394	0.6714730751779444
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.006718394	0.6714730751779444
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.006718394	0.6714730751779444
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.006718394	0.6714730751779444
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.006718394	0.6714730751779444
TETRASOMY X	0.006718394	0.6714730751779444
FUCOSIDOSIS	0.006718394	0.6714730751779444
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.006718394	0.6714730751779444
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.006718394	0.6714730751779444
WIEDEMANN-STEINER SYNDROME; WDSTS	0.006718394	0.6714730751779444
DISTAL MONOSOMY 6P	0.006718394	0.6714730751779444
17Q21.31 MICRODUPLICATION SYNDROME	0.006718394	0.6714730751779444
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.006718394	0.6714730751779444
OGDEN SYNDROME; OGDNS	0.006718394	0.6714730751779444
RECOMBINANT 8 SYNDROME	0.006718394	0.6714730751779444
CEDNIK SYNDROME	0.006718394	0.6714730751779444
SMITH-MAGENIS SYNDROME; SMS	0.006718394	0.6714730751779444
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.006718394	0.6714730751779444
ALSTROM SYNDROME; ALMS	0.006718394	0.6714730751779444
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.006718394	0.6714730751779444
GABRIELE-DE VRIES SYNDROME; GADEVS	0.006718394	0.6714730751779444
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.006718394	0.6714730751779444
KOOLEN-DE VRIES SYNDROME; KDVS	0.006718394	0.6714730751779444
DISTAL MONOSOMY 15Q	0.006718394	0.6714730751779444
COFFIN-SIRIS SYNDROME	0.006718394	0.6714730751779444
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.006718394	0.6714730751779444
8Q22.1 MICRODELETION SYNDROME	0.006718394	0.6714730751779444
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.006718394	0.6714730751779444
CRANIOFRONTONASAL SYNDROME; CFNS	0.006718394	0.6714730751779444
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.006718394	0.6714730751779444
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.006718394	0.6714730751779444
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.006718394	0.6714730751779444
15Q14 MICRODELETION SYNDROME	0.006718394	0.6714730751779444
MONOSOMY 9P	0.006718394	0.6714730751779444
PELGER-HUET ANOMALY; PHA	0.006718394	0.6714730751779444
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.006718394	0.6714730751779444
DISTAL MONOSOMY 9P	0.006718394	0.6714730751779444
RECOMBINANT CHROMOSOME 8 SYNDROME	0.006718394	0.6714730751779444
JABERI-ELAHI SYNDROME; JABELS	0.006718394	0.6714730751779444
ZTTK SYNDROME; ZTTKS	0.006718394	0.6714730751779444
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.006718394	0.6714730751779444
3Q29 MICRODUPLICATION SYNDROME	0.006718394	0.6714730751779444
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.006718394	0.6714730751779444
GALLOWAY-MOWAT SYNDROME	0.006718394	0.6714730751779444
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00617284	0.6169474218662112
PARAMOLAR TUBERCLE OF BOLK	0.00617284	0.6169474218662112
CORNEODERMATOOSSEOUS SYNDROME	0.00617284	0.6169474218662112
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00617284	0.6169474218662112
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00617284	0.6169474218662112
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.00617284	0.6169474218662112
BRITTLE CORNEA SYNDROME	0.00617284	0.6169474218662112
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.00617284	0.6169474218662112
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	0.00617284	0.6169474218662112
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00617284	0.6169474218662112
BARDET-BIEDL SYNDROME 4; BBS4	0.00617284	0.6169474218662112
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00617284	0.6169474218662112
LAMELLAR ICHTHYOSIS	0.00617284	0.6169474218662112
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00617284	0.6169474218662112
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.00617284	0.6169474218662112
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00617284	0.6169474218662112
TURNER SYNDROME	0.00617284	0.6169474218662112
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00617284	0.6169474218662112
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00617284	0.6169474218662112
MOEBIUS SYNDROME; MBS	0.00617284	0.6169474218662112
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00617284	0.6169474218662112
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.00617284	0.6169474218662112
MOLAR I REINCLUSION	0.00617284	0.6169474218662112
SEVERE COMBINED IMMUNODEFICIENCY	0.00617284	0.6169474218662112
SAGLIKER SYNDROME	0.00617284	0.6169474218662112
IRIDOGONIODYSGENESIS, TYPE 2	0.00617284	0.6169474218662112
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00617284	0.6169474218662112
XERODERMA PIGMENTOSUM	0.00617284	0.6169474218662112
PRIMARY HYPEROXALURIA TYPE 1	0.00617284	0.6169474218662112
CRANIOFRONTONASAL DYSPLASIA	0.00617284	0.6169474218662112
125300 DENS IN DENTE AND PALATAL INVAGINATIONS	0.00617284	0.6169474218662112
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.00617284	0.6169474218662112
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00617284	0.6169474218662112
CANINE TEETH, ABSENCE OF UPPER PERMANENT	0.00617284	0.6169474218662112
ERYTHEMA OF ACRAL REGIONS	0.00617284	0.6169474218662112
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.00617284	0.6169474218662112
LEGG-CALVÉ-PERTHES DISEASE	0.00617284	0.6169474218662112
BANGSTAD SYNDROME	0.00617284	0.6169474218662112
DENS EVAGINATUS	0.00617284	0.6169474218662112
EPILEPSY-TELANGIECTASIA SYNDROME	0.00617284	0.6169474218662112
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00617284	0.6169474218662112
CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH	0.00617284	0.6169474218662112
MONOSOMY X	0.00617284	0.6169474218662112
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.00617284	0.6169474218662112
MOSAIC MONOSOMY X	0.00617284	0.6169474218662112
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00617284	0.6169474218662112
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00617284	0.6169474218662112
BETA-THALASSEMIA MAJOR	0.00617284	0.6169474218662112
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.00617284	0.6169474218662112
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00617284	0.6169474218662112
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00617284	0.6169474218662112
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.00617284	0.6169474218662112
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00617284	0.6169474218662112
8Q21.11 MICRODELETION SYNDROME	0.00617284	0.6169474218662112
HEART-HAND SYNDROME TYPE 2	0.00617284	0.6169474218662112
FREEMAN-SHELDON SYNDROME	0.00617284	0.6169474218662112
JUVENILE PAGET DISEASE	0.00617284	0.6169474218662112
BRANCHIOOCULOFACIAL SYNDROME	0.00617284	0.6169474218662112
GAPO SYNDROME; GAPOS	0.00617284	0.6169474218662112
SPLIT LOWER LIP	0.00617284	0.6169474218662112
ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE	0.00617284	0.6169474218662112
ISOLATED HEMIHYPERPLASIA	0.00617284	0.6169474218662112
TEETH, ODD SHAPES OFLOBODONTIA, INCLUDED	0.00617284	0.6169474218662112
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00617284	0.6169474218662112
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00617284	0.6169474218662112
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00617284	0.6169474218662112
INCISORS, FUSED MANDIBULAR	0.00617284	0.6169474218662112
HYPOPHOSPHATASIA, INFANTILE	0.00617284	0.6169474218662112
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00617284	0.6169474218662112
STÜVE-WIEDEMANN SYNDROME	0.00617284	0.6169474218662112
TOOTH SIZE	0.00617284	0.6169474218662112
PREMATURE OVARIAN FAILURE 2B	0.00617284	0.6169474218662112
RETT SYNDROME; RTT	0.00617284	0.6169474218662112
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00617284	0.6169474218662112
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.00617284	0.6169474218662112
DEAFNESS-CRANIOFACIAL SYNDROME	0.00617284	0.6169474218662112
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00617284	0.6169474218662112
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00617284	0.6169474218662112
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00617284	0.6169474218662112
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00617284	0.6169474218662112
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.00617284	0.6169474218662112
RETT SYNDROME	0.00617284	0.6169474218662112
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.00617284	0.6169474218662112
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00617284	0.6169474218662112
HYPOPHOSPHATASIA	0.00617284	0.6169474218662112
MULTIPLE OSTEOCHONDROMAS	0.00617284	0.6169474218662112
VELO-FACIAL-SKELETAL SYNDROME	0.00617284	0.6169474218662112
FAMILIAL TUMORAL CALCINOSIS	0.00617284	0.6169474218662112
MONILETHRIX	0.00617284	0.6169474218662112
TEETH, FUSED	0.00617284	0.6169474218662112
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00617284	0.6169474218662112
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.00617284	0.6169474218662112
MARSHALL SYNDROME	0.00617284	0.6169474218662112
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.00617284	0.6169474218662112
AYME-GRIPP SYNDROME; AYGRP	0.00617284	0.6169474218662112
OSTEOGENESIS IMPERFECTA, TYPE V	0.00617284	0.6169474218662112
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.00617284	0.6169474218662112
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.05452565331173317
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.000545554	0.05452565331173317
CLASSIC PHENYLKETONURIA	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000545554	0.05452565331173317
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.000545554	0.05452565331173317
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000545554	0.05452565331173317
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.000545554	0.05452565331173317
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.000545554	0.05452565331173317
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.05452565331173317
EAST SYNDROME	0.000545554	0.05452565331173317
CONGENITAL HYPOTHYROIDISM	0.000545554	0.05452565331173317
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.05452565331173317
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000545554	0.05452565331173317
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000545554	0.05452565331173317
FLOATING-HARBOR SYNDROME	0.000545554	0.05452565331173317
BIOTINIDASE DEFICIENCY	0.000545554	0.05452565331173317
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000545554	0.05452565331173317
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000545554	0.05452565331173317
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.05452565331173317
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.000545554	0.05452565331173317
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
BOHRING-OPITZ SYNDROME	0.000545554	0.05452565331173317
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.05452565331173317
COG2-CDG	0.000545554	0.05452565331173317
PMM2-CDG	0.000545554	0.05452565331173317
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.05452565331173317
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.05452565331173317
OCCIPITAL HORN SYNDROME	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.05452565331173317
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.000545554	0.05452565331173317
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.05452565331173317
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.000545554	0.05452565331173317
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.05452565331173317
FETAL ALCOHOL SYNDROME	0.000545554	0.05452565331173317
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.05452565331173317
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.05452565331173317
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.05452565331173317
TOLUENE EMBRYOPATHY	0.000545554	0.05452565331173317
RIGID SPINE SYNDROME	0.000545554	0.05452565331173317
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.000545554	0.05452565331173317
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.05452565331173317
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.000545554	0.05452565331173317
RUBINSTEIN-TAYBI SYNDROME	0.000545554	0.05452565331173317
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.05452565331173317
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.000545554	0.05452565331173317
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.05452565331173317
GERODERMA OSTEODYSPLASTICA	0.000545554	0.05452565331173317
HYDROXYKYNURENINURIA	0.000545554	0.05452565331173317
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.05452565331173317
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.000545554	0.05452565331173317
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.05452565331173317
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.05452565331173317
MYOCLONIC-ASTASTIC EPILEPSY	0.000545554	0.05452565331173317
19P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.000545554	0.05452565331173317
ZEBRA BODY MYOPATHY	0.000545554	0.05452565331173317
GERMAN SYNDROME	0.000545554	0.05452565331173317
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.05452565331173317
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.05452565331173317
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000545554	0.05452565331173317
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.05452565331173317
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.000545554	0.05452565331173317
NEPHROGENIC DIABETES INSIPIDUS	0.000545554	0.05452565331173317
MEND SYNDROME	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.05452565331173317
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.05452565331173317
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.05452565331173317
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.05452565331173317
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.05452565331173317
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.05452565331173317
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.05452565331173317
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.05452565331173317
ICF SYNDROME	0.000545554	0.05452565331173317
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.05452565331173317
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.05452565331173317
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.05452565331173317
MICROVILLUS INCLUSION DISEASE	0.000545554	0.05452565331173317
KOOLEN-DE VRIES SYNDROME	0.000545554	0.05452565331173317
JACOBSEN SYNDROME	0.000545554	0.05452565331173317
GRISCELLI SYNDROME TYPE 1	0.000545554	0.05452565331173317
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000545554	0.05452565331173317
USHER SYNDROME TYPE 1	0.000545554	0.05452565331173317
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.000545554	0.05452565331173317
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000545554	0.05452565331173317
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.05452565331173317
OPTIC PATHWAY GLIOMA	0.000545554	0.05452565331173317
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000545554	0.05452565331173317
CUTIS LAXA	0.000545554	0.05452565331173317
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.05452565331173317
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.05452565331173317
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000545554	0.05452565331173317
PHACE SYNDROME	0.000545554	0.05452565331173317
ALG6-CDG	0.000545554	0.05452565331173317
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.05452565331173317
ALG3-CDG	0.000545554	0.05452565331173317
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.05452565331173317
DONNAI-BARROW SYNDROME	0.000545554	0.05452565331173317
X SMALL RINGS	0.000545554	0.05452565331173317
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000545554	0.05452565331173317
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.05452565331173317
RIDDLE SYNDROME	0.000545554	0.05452565331173317
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.05452565331173317
DYSTONIA-APHONIA SYNDROME	0.000545554	0.05452565331173317
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
HYDRANENCEPHALY	0.000545554	0.05452565331173317
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.05452565331173317
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.05452565331173317
JOUBERT SYNDROME WITH OCULAR DEFECT	0.000545554	0.05452565331173317
JOUBERT SYNDROME WITH RENAL DEFECT	0.000545554	0.05452565331173317
MATERNAL PHENYLKETONURIA	0.000545554	0.05452565331173317
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.000545554	0.05452565331173317
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.05452565331173317
ALG1-CDG	0.000545554	0.05452565331173317
HARTNUP DISEASE	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.05452565331173317
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000545554	0.05452565331173317
8Q24.3 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.05452565331173317
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.05452565331173317
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.05452565331173317
LEBER CONGENITAL AMAUROSIS	0.000545554	0.05452565331173317
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.05452565331173317
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.000545554	0.05452565331173317
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000545554	0.05452565331173317
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.05452565331173317
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.05452565331173317
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.000545554	0.05452565331173317
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.000545554	0.05452565331173317
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.000545554	0.05452565331173317
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.05452565331173317
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
VICI SYNDROME	0.000545554	0.05452565331173317
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000545554	0.05452565331173317
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.05452565331173317
16P13.2 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.05452565331173317
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.05452565331173317
PETERS PLUS SYNDROME	0.000545554	0.05452565331173317
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.05452565331173317
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.05452565331173317
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.000545554	0.05452565331173317
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.05452565331173317
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.05452565331173317
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.05452565331173317
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.05452565331173317
NIEMANN-PICK DISEASE TYPE C	0.000545554	0.05452565331173317
AICARDI-GOUTIÈRES SYNDROME	0.000545554	0.05452565331173317
MAPLE SYRUP URINE DISEASE	0.000545554	0.05452565331173317
NARP SYNDROME	0.000545554	0.05452565331173317
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.05452565331173317
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.05452565331173317
LIG4 SYNDROME	0.000545554	0.05452565331173317
MOSAIC TRISOMY 9	0.000545554	0.05452565331173317
MARINESCO-SJÖGREN SYNDROME	0.000545554	0.05452565331173317
CRANIOPHARYNGIOMA	0.000545554	0.05452565331173317
22Q11.2 DELETION SYNDROME	0.000545554	0.05452565331173317
XQ21 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
WYBURN-MASON SYNDROME	0.000545554	0.05452565331173317
RING CHROMOSOME 22 SYNDROME	0.000545554	0.05452565331173317
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.05452565331173317
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000545554	0.05452565331173317
MULTIPLE SULFATASE DEFICIENCY	0.000545554	0.05452565331173317
48,XYYY SYNDROME	0.000545554	0.05452565331173317
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.05452565331173317
ALPHA-MANNOSIDOSIS	0.000545554	0.05452565331173317
MEDULLOBLASTOMA	0.000545554	0.05452565331173317
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000545554	0.05452565331173317
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.05452565331173317
CINCA SYNDROME	0.000545554	0.05452565331173317
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.05452565331173317
PEDIATRIC-ONSET GRAVES DISEASE	0.000545554	0.05452565331173317
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.000545554	0.05452565331173317
NETHERTON SYNDROME	0.000545554	0.05452565331173317
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.000545554	0.05452565331173317
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.05452565331173317
XQ25 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
ALSTRÖM SYNDROME	0.000545554	0.05452565331173317
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.05452565331173317
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.000545554	0.05452565331173317
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000545554	0.05452565331173317
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.05452565331173317
TRISOMY 12P	0.000545554	0.05452565331173317
MOSAIC TRISOMY 14	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.000545554	0.05452565331173317
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
DISTAL TRISOMY 18Q	0.000545554	0.05452565331173317
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
6Q16 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
JOUBERT SYNDROME	0.000545554	0.05452565331173317
PYRUVATE DEHYDROGENASE DEFICIENCY	0.000545554	0.05452565331173317
22Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
DISTAL TRISOMY 6P	0.000545554	0.05452565331173317
TRISOMY 8Q	0.000545554	0.05452565331173317
RABSON-MENDENHALL SYNDROME	0.000545554	0.05452565331173317
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.000545554	0.05452565331173317
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.000545554	0.05452565331173317
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.05452565331173317
INFANTILE REFSUM DISEASE	0.000545554	0.05452565331173317
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.05452565331173317
DYSKERATOSIS CONGENITA	0.000545554	0.05452565331173317
TEMTAMY SYNDROME	0.000545554	0.05452565331173317
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.000545554	0.05452565331173317
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.000545554	0.05452565331173317
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.05452565331173317
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.05452565331173317
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.05452565331173317
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.000545554	0.05452565331173317
LATHOSTEROLOSIS	0.000545554	0.05452565331173317
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.05452565331173317
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.05452565331173317
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.000545554	0.05452565331173317
6Q TERMINAL DELETION SYNDROME	0.000545554	0.05452565331173317
MONOSOMY 18P	0.000545554	0.05452565331173317
MONOSOMY 18Q	0.000545554	0.05452565331173317
1P36 DELETION SYNDROME	0.000545554	0.05452565331173317
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.05452565331173317
2P21 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.05452565331173317
TRANSKETOLASE DEFICIENCY	0.000545554	0.05452565331173317
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.05452565331173317
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.000545554	0.05452565331173317
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.05452565331173317
KRABBE DISEASE	0.000545554	0.05452565331173317
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.05452565331173317
MONOSOMY 22Q13.3	0.000545554	0.05452565331173317
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.05452565331173317
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.05452565331173317
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.05452565331173317
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.05452565331173317
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.000545554	0.05452565331173317
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.05452565331173317
DEXTROCARDIA	0.000545554	0.05452565331173317
CHÉDIAK-HIGASHI SYNDROME	0.000545554	0.05452565331173317
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA TYPE 13	0.000545554	0.05452565331173317
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000545554	0.05452565331173317
WOLMAN DISEASE	0.000545554	0.05452565331173317
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.05452565331173317
PRADER-WILLI-LIKE SYNDROME	0.000545554	0.05452565331173317
DISTAL MONOSOMY 12Q	0.000545554	0.05452565331173317
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.05452565331173317
PERLMAN SYNDROME	0.000545554	0.05452565331173317
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000545554	0.05452565331173317
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.05452565331173317
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000545554	0.05452565331173317
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.05452565331173317
TRICHOTHIODYSTROPHY	0.000545554	0.05452565331173317
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.05452565331173317
PEHO SYNDROME	0.000545554	0.05452565331173317
FARBER DISEASE	0.000545554	0.05452565331173317
HURLER SYNDROME	0.000545554	0.05452565331173317
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.05452565331173317
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.05452565331173317
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.05452565331173317
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.05452565331173317
VASCULAR EHLERS-DANLOS SYNDROME	0.000545554	0.05452565331173317
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.05452565331173317
BRESEK SYNDROME	0.000545554	0.05452565331173317
PFEIFFER SYNDROME TYPE 2	0.000545554	0.05452565331173317
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.05452565331173317
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.05452565331173317
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.05452565331173317
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.05452565331173317
TARP SYNDROME	0.000545554	0.05452565331173317
TETRASOMY 5P	0.000545554	0.05452565331173317
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.05452565331173317
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.05452565331173317
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.05452565331173317
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000545554	0.05452565331173317
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.05452565331173317
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.000545554	0.05452565331173317
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.05452565331173317
KEUTEL SYNDROME	0.000545554	0.05452565331173317
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.05452565331173317
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.05452565331173317
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.05452565331173317
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.05452565331173317
OROFACIODIGITAL SYNDROME TYPE 6	0.000545554	0.05452565331173317
WILSON-TURNER SYNDROME	0.000545554	0.05452565331173317
L1 SYNDROME	0.000545554	0.05452565331173317
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.05452565331173317
10Q22.3Q23.3 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.000545554	0.05452565331173317
OGDEN SYNDROME	0.000545554	0.05452565331173317
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.05452565331173317
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000545554	0.05452565331173317
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.000545554	0.05452565331173317
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.000545554	0.05452565331173317
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.05452565331173317
WEAVER SYNDROME	0.000545554	0.05452565331173317
W SYNDROME	0.000545554	0.05452565331173317
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.05452565331173317
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.05452565331173317
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.05452565331173317
LATERAL MENINGOCELE SYNDROME	0.000545554	0.05452565331173317
TRISOMY 18	0.000545554	0.05452565331173317
DISTAL TRISOMY 17Q	0.000545554	0.05452565331173317
OTOFACIOCERVICAL SYNDROME	0.000545554	0.05452565331173317
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.05452565331173317
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.05452565331173317
TRISOMY X	0.000545554	0.05452565331173317
ALG11-CDG	0.000545554	0.05452565331173317
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.05452565331173317
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.05452565331173317
FG SYNDROME TYPE 1	0.000545554	0.05452565331173317
PITT-HOPKINS SYNDROME	0.000545554	0.05452565331173317
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.05452565331173317
OPITZ G/BBB SYNDROME	0.000545554	0.05452565331173317
FRIED SYNDROME	0.000545554	0.05452565331173317
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.05452565331173317
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000545554	0.05452565331173317
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.000545554	0.05452565331173317
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.05452565331173317
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.05452565331173317
OXOGLUTARIC ACIDURIA	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.05452565331173317
SIALIDOSIS TYPE 2	0.000545554	0.05452565331173317
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.05452565331173317
RUVALCABA SYNDROME	0.000545554	0.05452565331173317
SARCOSINEMIA	0.000545554	0.05452565331173317
SAY-BARBER-MILLER SYNDROME	0.000545554	0.05452565331173317
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.000545554	0.05452565331173317
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.000545554	0.05452565331173317
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.05452565331173317
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000545554	0.05452565331173317
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.05452565331173317
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.05452565331173317
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.000545554	0.05452565331173317
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.05452565331173317
DPAGT1-CDG	0.000545554	0.05452565331173317
SEVERE CANAVAN DISEASE	0.000545554	0.05452565331173317
CONGENITAL TOXOPLASMOSIS	0.000545554	0.05452565331173317
SENIOR-LOKEN SYNDROME	0.000545554	0.05452565331173317
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000545554	0.05452565331173317
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.05452565331173317
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.000545554	0.05452565331173317
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.05452565331173317
MEVALONIC ACIDURIA	0.000545554	0.05452565331173317
HEREDITARY FOLATE MALABSORPTION	0.000545554	0.05452565331173317
ISOVALERIC ACIDEMIA	0.000545554	0.05452565331173317
CONGENITAL VARICELLA SYNDROME	0.000545554	0.05452565331173317
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.05452565331173317
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.05452565331173317
ATELOSTEOGENESIS TYPE III	0.000545554	0.05452565331173317
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.05452565331173317
1P21.3 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.05452565331173317
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.05452565331173317
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.000545554	0.05452565331173317
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000545554	0.05452565331173317
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.000545554	0.05452565331173317
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.000545554	0.05452565331173317
WALKER-WARBURG SYNDROME	0.000545554	0.05452565331173317
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.000545554	0.05452565331173317
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.05452565331173317
FILIPPI SYNDROME	0.000545554	0.05452565331173317
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.05452565331173317
SRD5A3-CDG	0.000545554	0.05452565331173317
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.000545554	0.05452565331173317
HEREDITARY OROTIC ACIDURIA	0.000545554	0.05452565331173317
ARGININEMIA	0.000545554	0.05452565331173317
11P15.4 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
ABETAL34V AMYLOIDOSIS	0.000545554	0.05452565331173317
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000545554	0.05452565331173317
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.000545554	0.05452565331173317
PYRIDOXINE-DEPENDENT EPILEPSY	0.000545554	0.05452565331173317
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000545554	0.05452565331173317
YUNIS-VARON SYNDROME	0.000545554	0.05452565331173317
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.05452565331173317
MONOSOMY 13Q34	0.000545554	0.05452565331173317
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.05452565331173317
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.05452565331173317
SSR4-CDG	0.000545554	0.05452565331173317
STT3B-CDG	0.000545554	0.05452565331173317
1Q21.1 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
1Q21.1 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
STT3A-CDG	0.000545554	0.05452565331173317
MICRO SYNDROME	0.000545554	0.05452565331173317
2Q31.1 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.05452565331173317
THYROID HYPOPLASIA	0.000545554	0.05452565331173317
6Q25 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
8P11.2 DELETION SYNDROME	0.000545554	0.05452565331173317
8P23.1 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.05452565331173317
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000545554	0.05452565331173317
CK SYNDROME	0.000545554	0.05452565331173317
FREE SIALIC ACID STORAGE DISEASE	0.000545554	0.05452565331173317
THYROID HEMIAGENESIS	0.000545554	0.05452565331173317
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000545554	0.05452565331173317
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.05452565331173317
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.000545554	0.05452565331173317
19P13.12 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.05452565331173317
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.05452565331173317
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.05452565331173317
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.05452565331173317
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.05452565331173317
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.05452565331173317
SALT-AND-PEPPER SYNDROME	0.000545554	0.05452565331173317
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.05452565331173317
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.05452565331173317
1Q44 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.000545554	0.05452565331173317
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000545554	0.05452565331173317
SIALURIA	0.000545554	0.05452565331173317
DUANE RETRACTION SYNDROME	0.000545554	0.05452565331173317
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.000545554	0.05452565331173317
HSD10 DISEASE	0.000545554	0.05452565331173317
TRISOMY 9P	0.000545554	0.05452565331173317
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.05452565331173317
DISTAL MONOSOMY 10Q	0.000545554	0.05452565331173317
SCHIZENCEPHALY	0.000545554	0.05452565331173317
15Q11Q13 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.05452565331173317
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.000545554	0.05452565331173317
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.05452565331173317
DISTAL MONOSOMY 19P13.3	0.000545554	0.05452565331173317
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.05452565331173317
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.05452565331173317
GRISCELLI SYNDROME	0.000545554	0.05452565331173317
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.05452565331173317
SMITH-MAGENIS SYNDROME	0.000545554	0.05452565331173317
SIMPSON-GOLABI-BEHMEL SYNDROME	0.000545554	0.05452565331173317
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.05452565331173317
RFT1-CDG	0.000545554	0.05452565331173317
MARDEN-WALKER SYNDROME	0.000545554	0.05452565331173317
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.05452565331173317
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.000545554	0.05452565331173317
CITRULLINEMIA TYPE II	0.000545554	0.05452565331173317
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.000545554	0.05452565331173317
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.000545554	0.05452565331173317
OKAMOTO SYNDROME	0.000545554	0.05452565331173317
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.000545554	0.05452565331173317
SLC35A2-CDG	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.05452565331173317
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.05452565331173317
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.05452565331173317
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.05452565331173317
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.05452565331173317
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.000545554	0.05452565331173317
COG4-CDG	0.000545554	0.05452565331173317
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.05452565331173317
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.000545554	0.05452565331173317
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.000545554	0.05452565331173317
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.05452565331173317
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.000545554	0.05452565331173317
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000545554	0.05452565331173317
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.05452565331173317
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.05452565331173317
15Q24 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
BILATERAL POLYMICROGYRIA	0.000545554	0.05452565331173317
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.05452565331173317
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.05452565331173317
GALACTOSEMIA	0.000545554	0.05452565331173317
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.05452565331173317
EPIDERMAL NEVUS SYNDROME	0.000545554	0.05452565331173317
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.05452565331173317
ISOLATED PLAGIOCEPHALY	0.000545554	0.05452565331173317
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000545554	0.05452565331173317
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000545554	0.05452565331173317
PROPIONIC ACIDEMIA	0.000545554	0.05452565331173317
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000545554	0.05452565331173317
MIETENS SYNDROME	0.000545554	0.05452565331173317
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.05452565331173317
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.000545554	0.05452565331173317
N SYNDROME	0.000545554	0.05452565331173317
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.05452565331173317
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.000545554	0.05452565331173317
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.000545554	0.05452565331173317
DISTAL MONOSOMY 1Q	0.000545554	0.05452565331173317
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.05452565331173317
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
20Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.05452565331173317
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
16P13.11 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
17Q12 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.05452565331173317
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.05452565331173317
TRISOMY 17P	0.000545554	0.05452565331173317
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.05452565331173317
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.000545554	0.05452565331173317
20P12.3 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
ATHYREOSIS	0.000545554	0.05452565331173317
THYROID ECTOPIA	0.000545554	0.05452565331173317
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.05452565331173317
TAY-SACHS DISEASE	0.000545554	0.05452565331173317
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
2P15P16.1 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
XP21 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.000545554	0.05452565331173317
CANAVAN DISEASE	0.000545554	0.05452565331173317
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.05452565331173317
NOONAN SYNDROME 3; NS3	0.000545554	0.05452565331173317
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000545554	0.05452565331173317
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000545554	0.05452565331173317
FRIAS SYNDROME	0.000545554	0.05452565331173317
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.05452565331173317
CHROMOSOME 10Q26 DELETION SYNDROME	0.000545554	0.05452565331173317
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.05452565331173317
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.05452565331173317
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.05452565331173317
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.05452565331173317
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000545554	0.05452565331173317
SCHINDLER DISEASE, TYPE I	0.000545554	0.05452565331173317
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.000545554	0.05452565331173317
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.05452565331173317
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.000545554	0.05452565331173317
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000545554	0.05452565331173317
EMANUEL SYNDROME	0.000545554	0.05452565331173317
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.05452565331173317
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000545554	0.05452565331173317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.05452565331173317
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.000545554	0.05452565331173317
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.05452565331173317
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.05452565331173317
LARSEN-LIKE SYNDROME	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000545554	0.05452565331173317
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.05452565331173317
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.05452565331173317
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000545554	0.05452565331173317
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.05452565331173317
JOUBERT SYNDROME 7	0.000545554	0.05452565331173317
NOONAN SYNDROME 5; NS5	0.000545554	0.05452565331173317
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000545554	0.05452565331173317
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000545554	0.05452565331173317
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000545554	0.05452565331173317
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.05452565331173317
HOLOPROSENCEPHALY 7	0.000545554	0.05452565331173317
CORNELIA DE LANGE SYNDROME 3	0.000545554	0.05452565331173317
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.05452565331173317
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.05452565331173317
JOUBERT SYNDROME 6	0.000545554	0.05452565331173317
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000545554	0.05452565331173317
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000545554	0.05452565331173317
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.05452565331173317
MEVALONIC ACIDURIA; MEVA	0.000545554	0.05452565331173317
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.000545554	0.05452565331173317
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.05452565331173317
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.05452565331173317
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.05452565331173317
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.000545554	0.05452565331173317
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000545554	0.05452565331173317
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000545554	0.05452565331173317
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000545554	0.05452565331173317
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.05452565331173317
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.05452565331173317
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.05452565331173317
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.05452565331173317
NOONAN SYNDROME 2; NS2	0.000545554	0.05452565331173317
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.05452565331173317
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.05452565331173317
SALLA DISEASE	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000545554	0.05452565331173317
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000545554	0.05452565331173317
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.05452565331173317
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.05452565331173317
CDAGS SYNDROME	0.000545554	0.05452565331173317
MUENKE SYNDROME	0.000545554	0.05452565331173317
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.05452565331173317
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.05452565331173317
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.05452565331173317
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.05452565331173317
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000545554	0.05452565331173317
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000545554	0.05452565331173317
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000545554	0.05452565331173317
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.05452565331173317
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000545554	0.05452565331173317
TIMOTHY SYNDROME; TS	0.000545554	0.05452565331173317
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.05452565331173317
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.05452565331173317
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.05452565331173317
FRONTOOCULAR SYNDROME	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.05452565331173317
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.05452565331173317
PROPIONIC ACIDEMIA	0.000545554	0.05452565331173317
KAGAMI-OGATA SYNDROME	0.000545554	0.05452565331173317
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.000545554	0.05452565331173317
JOUBERT SYNDROME 2	0.000545554	0.05452565331173317
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.05452565331173317
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.05452565331173317
CHROMOSOME 1P36 DELETION SYNDROME	0.000545554	0.05452565331173317
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.05452565331173317
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.05452565331173317
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.05452565331173317
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000545554	0.05452565331173317
LISSENCEPHALY 1; LIS1	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.05452565331173317
HURLER SYNDROME	0.000545554	0.05452565331173317
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.05452565331173317
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.05452565331173317
FUMARASE DEFICIENCY; FMRD	0.000545554	0.05452565331173317
LIG4 SYNDROME	0.000545554	0.05452565331173317
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.05452565331173317
PHELAN-MCDERMID SYNDROME	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.05452565331173317
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000545554	0.05452565331173317
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000545554	0.05452565331173317
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000545554	0.05452565331173317
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000545554	0.05452565331173317
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000545554	0.05452565331173317
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.000545554	0.05452565331173317
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.05452565331173317
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000545554	0.05452565331173317
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.05452565331173317
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000545554	0.05452565331173317
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.05452565331173317
HOLOPROSENCEPHALY 11	0.000545554	0.05452565331173317
ADAMS-OLIVER SYNDROME 2; AOS2	0.000545554	0.05452565331173317
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000545554	0.05452565331173317
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.05452565331173317
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.05452565331173317
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000545554	0.05452565331173317
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.05452565331173317
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000545554	0.05452565331173317
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000545554	0.05452565331173317
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000545554	0.05452565331173317
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.000545554	0.05452565331173317
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000545554	0.05452565331173317
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.05452565331173317
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.05452565331173317
LISSENCEPHALY 4	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000545554	0.05452565331173317
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.05452565331173317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.05452565331173317
JOUBERT SYNDROME 14	0.000545554	0.05452565331173317
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.000545554	0.05452565331173317
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.05452565331173317
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000545554	0.05452565331173317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.05452565331173317
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.05452565331173317
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.05452565331173317
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000545554	0.05452565331173317
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.05452565331173317
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000545554	0.05452565331173317
PONTINE TEGMENTAL CAP DYSPLASIA	0.000545554	0.05452565331173317
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000545554	0.05452565331173317
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000545554	0.05452565331173317
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.05452565331173317
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.05452565331173317
COFFIN-SIRIS SYNDROME 4; CSS4	0.000545554	0.05452565331173317
COFFIN-SIRIS SYNDROME 2; CSS2	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000545554	0.05452565331173317
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000545554	0.05452565331173317
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.05452565331173317
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.05452565331173317
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000545554	0.05452565331173317
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.05452565331173317
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000545554	0.05452565331173317
JOUBERT SYNDROME 15	0.000545554	0.05452565331173317
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.05452565331173317
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.05452565331173317
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.05452565331173317
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.000545554	0.05452565331173317
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.05452565331173317
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.05452565331173317
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000545554	0.05452565331173317
HADZISELIMOVIC SYNDROME	0.000545554	0.05452565331173317
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.05452565331173317
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000545554	0.05452565331173317
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.05452565331173317
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000545554	0.05452565331173317
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000545554	0.05452565331173317
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.05452565331173317
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000545554	0.05452565331173317
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.05452565331173317
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.000545554	0.05452565331173317
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000545554	0.05452565331173317
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.05452565331173317
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000545554	0.05452565331173317
JOUBERT SYNDROME 8	0.000545554	0.05452565331173317
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.05452565331173317
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000545554	0.05452565331173317
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.05452565331173317
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.000545554	0.05452565331173317
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000545554	0.05452565331173317
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.05452565331173317
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.05452565331173317
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.05452565331173317
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000545554	0.05452565331173317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.05452565331173317
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.05452565331173317
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.05452565331173317
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.05452565331173317
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000545554	0.05452565331173317
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.05452565331173317
CHROMOSOME 19P13.13 DELETION SYNDROME	0.000545554	0.05452565331173317
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.05452565331173317
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000545554	0.05452565331173317
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.05452565331173317
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.05452565331173317
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.05452565331173317
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.05452565331173317
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.05452565331173317
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.05452565331173317
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.000545554	0.05452565331173317
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.05452565331173317
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.05452565331173317
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.05452565331173317
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.05452565331173317
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.05452565331173317
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.05452565331173317
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000545554	0.05452565331173317
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.05452565331173317
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.05452565331173317
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.05452565331173317
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.05452565331173317
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.05452565331173317
MACDERMOT-WINTER SYNDROME	0.000545554	0.05452565331173317
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.000545554	0.05452565331173317
LANDAU-KLEFFNER SYNDROME	0.000545554	0.05452565331173317
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000545554	0.05452565331173317
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.05452565331173317
KETOADIPICACIDURIA	0.000545554	0.05452565331173317
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.05452565331173317
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.05452565331173317
ARIMA SYNDROME	0.000545554	0.05452565331173317
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000545554	0.05452565331173317
VICI SYNDROME; VICIS	0.000545554	0.05452565331173317
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000545554	0.05452565331173317
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.05452565331173317
HYPERPROLINEMIA, TYPE I	0.000545554	0.05452565331173317
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000545554	0.05452565331173317
HYDROXYKYNURENINURIA	0.000545554	0.05452565331173317
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.05452565331173317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000545554	0.05452565331173317
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.05452565331173317
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000545554	0.05452565331173317
HOLOPROSENCEPHALY 1; HPE1	0.000545554	0.05452565331173317
HARTNUP DISORDER	0.000545554	0.05452565331173317
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.05452565331173317
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.05452565331173317
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000545554	0.05452565331173317
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.05452565331173317
GAUCHER DISEASE, TYPE II	0.000545554	0.05452565331173317
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.05452565331173317
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.000545554	0.05452565331173317
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.05452565331173317
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.05452565331173317
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000545554	0.05452565331173317
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.05452565331173317
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000545554	0.05452565331173317
ELEJALDE DISEASE	0.000545554	0.05452565331173317
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000545554	0.05452565331173317
NETHERTON SYNDROME; NETH	0.000545554	0.05452565331173317
LEIGH SYNDROME; LS	0.000545554	0.05452565331173317
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.05452565331173317
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000545554	0.05452565331173317
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000545554	0.05452565331173317
MUCOLIPIDOSIS IV; ML4	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.000545554	0.05452565331173317
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.000545554	0.05452565331173317
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.05452565331173317
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.05452565331173317
JAWAD SYNDROME	0.000545554	0.05452565331173317
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.05452565331173317
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000545554	0.05452565331173317
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.05452565331173317
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000545554	0.05452565331173317
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000545554	0.05452565331173317
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.05452565331173317
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000545554	0.05452565331173317
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.05452565331173317
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.05452565331173317
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.05452565331173317
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.05452565331173317
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000545554	0.05452565331173317
FOLATE MALABSORPTION, HEREDITARY	0.000545554	0.05452565331173317
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000545554	0.05452565331173317
CHROMOSOME 2Q37 DELETION SYNDROME	0.000545554	0.05452565331173317
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.05452565331173317
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.05452565331173317
SEPTOOPTIC DYSPLASIA	0.000545554	0.05452565331173317
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000545554	0.05452565331173317
CURRARINO SYNDROME	0.000545554	0.05452565331173317
PRADER-WILLI SYNDROME; PWS	0.000545554	0.05452565331173317
CHAR SYNDROME	0.000545554	0.05452565331173317
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.05452565331173317
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.05452565331173317
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.05452565331173317
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.05452565331173317
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.05452565331173317
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.05452565331173317
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.05452565331173317
MYHRE SYNDROME	0.000545554	0.05452565331173317
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.000545554	0.05452565331173317
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.05452565331173317
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.05452565331173317
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.05452565331173317
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.05452565331173317
ANGELMAN SYNDROME	0.000545554	0.05452565331173317
ADAMS-OLIVER SYNDROME 1; AOS1	0.000545554	0.05452565331173317
8P23.1 DUPLICATION SYNDROME	0.000545554	0.05452565331173317
12Q14 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
XQ28 (MECP2) DUPLICATION	0.000545554	0.05452565331173317
3Q29 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
POTOCKI-SHAFFER SYNDROME	0.000545554	0.05452565331173317
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.05452565331173317
DIGEORGE SYNDROME; DGS	0.000545554	0.05452565331173317
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.05452565331173317
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000545554	0.05452565331173317
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000545554	0.05452565331173317
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.05452565331173317
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000545554	0.05452565331173317
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000545554	0.05452565331173317
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.05452565331173317
TEMTAMY SYNDROME; TEMTYS	0.000545554	0.05452565331173317
COSTELLO SYNDROME; CSTLO	0.000545554	0.05452565331173317
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.05452565331173317
COACH SYNDROME	0.000545554	0.05452565331173317
CITRULLINEMIA, CLASSIC	0.000545554	0.05452565331173317
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.05452565331173317
JOUBERT SYNDROME 1	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.000545554	0.05452565331173317
C SYNDROME	0.000545554	0.05452565331173317
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000545554	0.05452565331173317
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000545554	0.05452565331173317
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.05452565331173317
BARDET-BIEDL SYNDROME 1; BBS1	0.000545554	0.05452565331173317
AUSTRALIA ANTIGEN	0.000545554	0.05452565331173317
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.05452565331173317
ARGININOSUCCINIC ACIDURIA	0.000545554	0.05452565331173317
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.05452565331173317
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.05452565331173317
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000545554	0.05452565331173317
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.000545554	0.05452565331173317
NAVAJO NEUROHEPATOPATHY	0.000545554	0.05452565331173317
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.05452565331173317
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.05452565331173317
SHUKLA-VERNON SYNDROME; SHUVER	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.05452565331173317
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.05452565331173317
XQ25 DUPLICATION SYNDROME	0.000545554	0.05452565331173317
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.000545554	0.05452565331173317
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.05452565331173317
MEND SYNDROME; MEND	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.05452565331173317
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.000545554	0.05452565331173317
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.000545554	0.05452565331173317
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.000545554	0.05452565331173317
BARATELA-SCOTT SYNDROME	0.000545554	0.05452565331173317
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.05452565331173317
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.000545554	0.05452565331173317
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000545554	0.05452565331173317
LISSENCEPHALY 2; LIS2	0.000545554	0.05452565331173317
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.000545554	0.05452565331173317
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.05452565331173317
BAND HETEROTOPIA; BH	0.000545554	0.05452565331173317
OCULOECTODERMAL SYNDROME; OES	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.05452565331173317
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000545554	0.05452565331173317
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.05452565331173317
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.05452565331173317
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.05452565331173317
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000545554	0.05452565331173317
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.05452565331173317
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.05452565331173317
WIEACKER-WOLFF SYNDROME	0.000545554	0.05452565331173317
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000545554	0.05452565331173317
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000545554	0.05452565331173317
PELIZAEUS-MERZBACHER DISEASE	0.000545554	0.05452565331173317
TARP SYNDROME; TARPS	0.000545554	0.05452565331173317
WAISMAN SYNDROME; WSMN	0.000545554	0.05452565331173317
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED 9	0.000545554	0.05452565331173317
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000545554	0.05452565331173317
GLYCEROL KINASE DEFICIENCY; GKD	0.000545554	0.05452565331173317
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.05452565331173317
PETTIGREW SYNDROME	0.000545554	0.05452565331173317
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.05452565331173317
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000545554	0.05452565331173317
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000545554	0.05452565331173317
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.05452565331173317
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.05452565331173317
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.05452565331173317
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.05452565331173317
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.05452565331173317
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.05452565331173317
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.000545554	0.05452565331173317
INFANTILE SIALIC ACID STORAGE DISEASE	0.000545554	0.05452565331173317
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.05452565331173317
REVESZ SYNDROME	0.000545554	0.05452565331173317
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000545554	0.05452565331173317
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.05452565331173317
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.05452565331173317
PYRUVATE CARBOXYLASE DEFICIENCY	0.000545554	0.05452565331173317
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000545554	0.05452565331173317
3MC SYNDROME 2	0.000545554	0.05452565331173317
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.05452565331173317
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.05452565331173317
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.05452565331173317
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000545554	0.05452565331173317
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000545554	0.05452565331173317
PETERS-PLUS SYNDROME; PTRPLS	0.000545554	0.05452565331173317
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.000545554	0.05452565331173317
PELLAGRA-LIKE SYNDROME	0.000545554	0.05452565331173317
PEHO SYNDROME; PEHO	0.000545554	0.05452565331173317
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.05452565331173317
RAINE SYNDROME	0.000545554	0.05452565331173317
OROTIC ACIDURIA	0.000545554	0.05452565331173317
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.05452565331173317
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.05452565331173317
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.05452565331173317
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.05452565331173317
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED 90	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000545554	0.05452565331173317
JOUBERT SYNDROME 10	0.000545554	0.05452565331173317
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000545554	0.05452565331173317
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.05452565331173317
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000545554	0.05452565331173317
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.05452565331173317
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000545554	0.05452565331173317
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000545554	0.05452565331173317
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.000545554	0.05452565331173317
OROFACIODIGITAL SYNDROME VI	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.05452565331173317
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.000545554	0.05452565331173317
MEHMO SYNDROME; MEHMO	0.000545554	0.05452565331173317
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.05452565331173317
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.05452565331173317
WEAVER SYNDROME	0.000545554	0.05452565331173317
WAARDENBURG-SHAH SYNDROME	0.000545554	0.05452565331173317
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.05452565331173317
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.05452565331173317
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.000545554	0.05452565331173317
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.05452565331173317
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000545554	0.05452565331173317
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.05452565331173317
17Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000545554	0.05452565331173317
KLEEFSTRA SYNDROME 2; KLEFS2	0.000545554	0.05452565331173317
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.05452565331173317
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.05452565331173317
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000545554	0.05452565331173317
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.05452565331173317
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.05452565331173317
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.05452565331173317
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000545554	0.05452565331173317
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000545554	0.05452565331173317
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.05452565331173317
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000545554	0.05452565331173317
AL KAISSI SYNDROME; ALKAS	0.000545554	0.05452565331173317
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.05452565331173317
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000545554	0.05452565331173317
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.05452565331173317
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.05452565331173317
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000545554	0.05452565331173317
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.05452565331173317
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.05452565331173317
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.05452565331173317
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.05452565331173317
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.000545554	0.05452565331173317
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000545554	0.05452565331173317
CHROMOSOME 1P35 DELETION SYNDROME	0.000545554	0.05452565331173317
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000545554	0.05452565331173317
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000545554	0.05452565331173317
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000545554	0.05452565331173317
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.05452565331173317
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000545554	0.05452565331173317
COFFIN-SIRIS SYNDROME 6; CSS6	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000545554	0.05452565331173317
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000545554	0.05452565331173317
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000545554	0.05452565331173317
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.05452565331173317
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.05452565331173317
SOTOS SYNDROME	0.000545554	0.05452565331173317
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.000545554	0.05452565331173317
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.05452565331173317
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.05452565331173317
OPTIC ATROPHY 11; OPA11	0.000545554	0.05452565331173317
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.05452565331173317
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.05452565331173317
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000545554	0.05452565331173317
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000545554	0.05452565331173317
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.000545554	0.05452565331173317
LISSENCEPHALY 8; LIS8	0.000545554	0.05452565331173317
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000545554	0.05452565331173317
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000545554	0.05452565331173317
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.05452565331173317
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000545554	0.05452565331173317
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.000545554	0.05452565331173317
SHASHI-PENA SYNDROME; SHAPNS	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.000545554	0.05452565331173317
HAREL-YOON SYNDROME; HAYOS	0.000545554	0.05452565331173317
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.05452565331173317
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000545554	0.05452565331173317
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.05452565331173317
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.000545554	0.05452565331173317
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.05452565331173317
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000545554	0.05452565331173317
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.05452565331173317
MECKEL SYNDROME 13; MKS13	0.000545554	0.05452565331173317
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.05452565331173317
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.05452565331173317
RAHMAN SYNDROME	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.05452565331173317
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000545554	0.05452565331173317
PEHO-LIKE SYNDROME; PEHOL	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000545554	0.05452565331173317
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000545554	0.05452565331173317
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.05452565331173317
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000545554	0.05452565331173317
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.05452565331173317
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.05452565331173317
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000545554	0.05452565331173317
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.05452565331173317
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000545554	0.05452565331173317
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.000545554	0.05452565331173317
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.05452565331173317
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000545554	0.05452565331173317
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.000545554	0.05452565331173317
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.05452565331173317
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.05452565331173317
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000545554	0.05452565331173317
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000545554	0.05452565331173317
TURNPENNY-FRY SYNDROME; TPFS	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000545554	0.05452565331173317
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.05452565331173317
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000545554	0.05452565331173317
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.05452565331173317
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000545554	0.05452565331173317
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.05452565331173317
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000545554	0.05452565331173317
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000545554	0.05452565331173317
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000545554	0.05452565331173317
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.05452565331173317
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.05452565331173317
AURICULOCONDYLAR SYNDROME	0.000545554	0.05452565331173317
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000545554	0.05452565331173317
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.05452565331173317
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000545554	0.05452565331173317
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.05452565331173317
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
PENTASOMY X	0.000545554	0.05452565331173317
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05452565331173317
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.000545554	0.05452565331173317
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.05452565331173317
TRANSALDOLASE DEFICIENCY	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.05452565331173317
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.000545554	0.05452565331173317
2Q37 MICRODELETION SYNDROME	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.05452565331173317
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.05452565331173317
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.05452565331173317
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000545554	0.05452565331173317
NOONAN SYNDROME 11; NS11	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000545554	0.05452565331173317
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000545554	0.05452565331173317
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.000545554	0.05452565331173317
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.000545554	0.05452565331173317
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.05452565331173317
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000545554	0.05452565331173317
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000545554	0.05452565331173317
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000545554	0.05452565331173317
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.000545554	0.05452565331173317
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.000545554	0.05452565331173317
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.05452565331173317
COFFIN-SIRIS SYNDROME 7; CSS7	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000545554	0.05452565331173317
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.05452565331173317
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000545554	0.05452565331173317
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.05452565331173317
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.05452565331173317
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.05452565331173317
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000545554	0.05452565331173317
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000545554	0.05452565331173317
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.05452565331173317
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000545554	0.05452565331173317
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.05452565331173317
BAKER-GORDON SYNDROME; BAGOS	0.000545554	0.05452565331173317
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.05452565331173317
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.05452565331173317
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000545554	0.05452565331173317
HELSMOORTEL-VAN DER AA SYNDROME	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.05452565331173317
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000545554	0.05452565331173317
CULLER-JONES SYNDROME; CJS	0.000545554	0.05452565331173317
AICARDI-GOUTIERES SYNDROME 7	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.05452565331173317
XIA-GIBBS SYNDROME	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.05452565331173317
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.05452565331173317
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.05452565331173317
SECKEL SYNDROME 8; SCKL8	0.000545554	0.05452565331173317
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000545554	0.05452565331173317
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000545554	0.05452565331173317
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.05452565331173317
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000545554	0.05452565331173317
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.05452565331173317
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.05452565331173317
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000545554	0.05452565331173317
CHROMOSOME 5Q12 DELETION SYNDROME	0.000545554	0.05452565331173317
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.05452565331173317
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.05452565331173317
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.05452565331173317
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.05452565331173317
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000545554	0.05452565331173317
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000545554	0.05452565331173317
CATEL-MANZKE SYNDROME; CATMANS	0.000545554	0.05452565331173317
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.05452565331173317
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.05452565331173317
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.05452565331173317
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.05452565331173317
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.05452565331173317
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.05452565331173317
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.05452565331173317
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.05452565331173317
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.05452565331173317
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.05452565331173317
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.05452565331173317
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.05452565331173317
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.05452565331173317
BARDET-BIEDL SYNDROME 2	0.000545554	0.05452565331173317
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000545554	0.05452565331173317
ALAZAMI-YUAN SYNDROME	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.000545554	0.05452565331173317
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.05452565331173317
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.05452565331173317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.05452565331173317
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.05452565331173317
STEEL SYNDROME; STLS	0.000545554	0.05452565331173317
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.05452565331173317
TYSHCHENKO SYNDROME	0.000545554	0.05452565331173317
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.05452565331173317
ALAZAMI SYNDROME; ALAZS	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.000545554	0.05452565331173317
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.05452565331173317
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000545554	0.05452565331173317
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.05452565331173317
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.05452565331173317
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000545554	0.05452565331173317
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.000545554	0.05452565331173317
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.05452565331173317
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000545554	0.05452565331173317
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.05452565331173317
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.05452565331173317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000545554	0.05452565331173317
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.05452565331173317
JOUBERT SYNDROME 21	0.000545554	0.05452565331173317
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000545554	0.05452565331173317
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.05452565331173317
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000545554	0.05452565331173317
SCHAAF-YANG SYNDROME; SHFYNG	0.000545554	0.05452565331173317
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.05452565331173317
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.05452565331173317
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.05452565331173317
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.000545554	0.05452565331173317
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.05452565331173317
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.05452565331173317
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.05452565331173317
INFANTILE LIVER FAILURE SYNDROME 1	0.000545554	0.05452565331173317
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.000545554	0.05452565331173317
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.05452565331173317
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.05452565331173317
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.000545554	0.05452565331173317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000545554	0.05452565331173317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.05452565331173317
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.000545554	0.05452565331173317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.05452565331173317
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.05452565331173317
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.05452565331173317
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.05452565331173317
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.05452565331173317
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.05452565331173317
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.000545554	0.05452565331173317
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000545554	0.05452565331173317
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.05452565331173317
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.05452565331173317
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000545554	0.05452565331173317
EVEN-PLUS SYNDROME	0.000545554	0.05452565331173317
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.05452565331173317
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.05452565331173317
LUSCAN-LUMISH SYNDROME; LLS	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.05452565331173317
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.05452565331173317
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.05452565331173317
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.000545554	0.05452565331173317
LAMB-SHAFFER SYNDROME	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.05452565331173317
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.05452565331173317
JOUBERT SYNDROME 26	0.000545554	0.05452565331173317
JOUBERT SYNDROME 25	0.000545554	0.05452565331173317
SECKEL SYNDROME 9; SCKL9	0.000545554	0.05452565331173317
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.05452565331173317
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.000545554	0.05452565331173317
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.05452565331173317
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.05452565331173317
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.05452565331173317
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.05452565331173317
JOUBERT SYNDROME 28	0.000545554	0.05452565331173317
JOUBERT SYNDROME 27	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.05452565331173317
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.000545554	0.05452565331173317
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.05452565331173317
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000545554	0.05452565331173317
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000545554	0.05452565331173317
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.000545554	0.05452565331173317
MEIER-GORLIN SYNDROME 7	0.000545554	0.05452565331173317
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.000545554	0.05452565331173317
MIRAGE SYNDROME; MIRAGE	0.000545554	0.05452565331173317
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.05452565331173317
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.05452565331173317
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000545554	0.05452565331173317
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.05452565331173317
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.05452565331173317
COFFIN-SIRIS SYNDROME 5	0.000545554	0.05452565331173317
HEART AND BRAIN MALFORMATION SYNDROME	0.000545554	0.05452565331173317
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.05452565331173317
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000545554	0.05452565331173317
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000545554	0.05452565331173317
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000545554	0.05452565331173317
AL-RAQAD SYNDROME; ARS	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.05452565331173317
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.05452565331173317
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000545554	0.05452565331173317
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000545554	0.05452565331173317
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000545554	0.05452565331173317
CHOPS SYNDROME; CHOPS	0.000545554	0.05452565331173317
WHITE-SUTTON SYNDROME; WHSUS	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000545554	0.05452565331173317
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000545554	0.05452565331173317
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000545554	0.05452565331173317
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.05452565331173317
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.05452565331173317
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.000545554	0.05452565331173317
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.05452565331173317
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.05452565331173317
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.05452565331173317
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.000545554	0.05452565331173317
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.05452565331173317
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.05452565331173317
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.05452565331173317
SENIOR-LOKEN SYNDROME 9	0.000545554	0.05452565331173317
DESANTO-SHINAWI SYNDROME	0.000545554	0.05452565331173317
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.05452565331173317
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.000545554	0.05452565331173317
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.05452565331173317
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.000545554	0.05452565331173317
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000545554	0.05452565331173317
JOUBERT SYNDROME 24	0.000545554	0.05452565331173317
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.05452565331173317
ROIFMAN SYNDROME; RFMN	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000545554	0.05452565331173317
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.05452565331173317
RING CHROMOSOME 14 SYNDROME	0.000545554	0.05452565331173317
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.05452565331173317
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000545554	0.05452565331173317
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.05452565331173317
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.000545554	0.05452565331173317
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000545554	0.05452565331173317
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.05452565331173317
NOONAN SYNDROME 9; NS9	0.000545554	0.05452565331173317
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000545554	0.05452565331173317
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.05452565331173317
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.05452565331173317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.05452565331173317
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.05452565331173317
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.05452565331173317
